<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD with MathML3 v1.1 20151215//EN" "JATS-journalpublishing1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink"
         dtd-version="1.1"
         xml:lang="sl"
         article-type="other">
   <front>
      <journal-meta>
         <journal-id journal-id-type="publisher-id">Zdrav Vestn</journal-id>
         <journal-id journal-id-type="nlm-ta">Zdrav Vestn</journal-id>
         <journal-id journal-id-type="doi">Zdrav Vestn</journal-id>
         <journal-title-group>
            <journal-title>Zdravniški vestnik</journal-title>
            <trans-title-group xml:lang="en">
               <trans-title>Slovenian Medical Journal</trans-title>
            </trans-title-group>
            <abbrev-journal-title>Zdrav Vestn</abbrev-journal-title>
         </journal-title-group>
         <issn publication-format="ppub" pub-type="ppub">1318-0347</issn>
         <issn publication-format="epub" pub-type="epub">1581-0224</issn>
         <issn-l>0350-0063</issn-l>
         <publisher>
            <publisher-name xml:lang="sl">Slovensko zdravniško društvo</publisher-name>
            <publisher-name xml:lang="en">Slovenian Medical Association</publisher-name>
            <publisher-loc xml:lang="sl">Ljubljana, Slovenia</publisher-loc>
         </publisher>
      </journal-meta>
      <article-meta>
         <article-id pub-id-type="doi">10.6016/ZdravVestn.2845</article-id>
         <article-id pub-id-type="publisher-id">2845</article-id>
         <article-categories>
            <subj-group subj-group-type="discipline" xml:lang="en">
               <subject>Medicine and health sciences</subject>
               <subj-group>
                  <subject>Oncology</subject>
               </subj-group>
            </subj-group>
            <subj-group subj-group-type="discipline" xml:lang="sl">
               <subject>Medicina/Zdravstvo</subject>
               <subj-group>
                  <subject>Onkologija</subject>
               </subj-group>
            </subj-group>
            <subj-group subj-group-type="article-type" xml:lang="en">
               <subject>Original scientific article</subject>
            </subj-group>
            <subj-group subj-group-type="article-type" xml:lang="sl">
               <subject>Izvirni znanstveni članek</subject>
            </subj-group>
            <subj-group subj-group-type="heading" xml:lang="sl">
               <subject>Onkologija</subject>
            </subj-group>
         </article-categories>
         <title-group>
            <article-title xml:lang="sl">Rak ustnega predela v Sloveniji v letih 1985–2014</article-title>
            <trans-title-group>
               <trans-title xml:lang="en">Oral cancer in Slovenia, 1985–2014</trans-title>
            </trans-title-group>
            <alt-title alt-title-type="running-head" xml:lang="sl">Rak ustnega predela v Sloveniji v letih 1985–2014</alt-title>
         </title-group>
         <contrib-group>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Blatnik</surname>
                  <given-names>Jona</given-names>
               </name>
               <xref ref-type="aff" rid="aff1">1</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Zadnik</surname>
                  <given-names>Vesna</given-names>
               </name>
               <xref ref-type="aff" rid="aff2">2</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Artnik</surname>
                  <given-names>Barbara</given-names>
               </name>
               <xref ref-type="aff" rid="aff3">3</xref>
               <xref ref-type="corresp" rid="corr"/>
            </contrib>
         </contrib-group>
         <aff-alternatives id="aff1">
            <aff xml:lang="sl">
               <label>1</label>
               <institution>Nacionalni inštitut za javno zdravje, Slovenija</institution>
            </aff>
            <aff xml:lang="en">
               <label>1</label>
               <institution>National Institute of Public Health, Slovenia</institution>
            </aff>
         </aff-alternatives>
         <aff-alternatives id="aff2">
            <aff xml:lang="sl">
               <label>2</label>
               <institution>Epidemiologija in register raka Republike Slovenije, Onkološki inštitut Ljubljana, Ljubljana, Slovenija</institution>
            </aff>
            <aff xml:lang="en">
               <label>2</label>
               <institution>Slovenian Cancer Registry, Institute of Oncology Ljubljana, Ljubljana, Slovenia</institution>
            </aff>
         </aff-alternatives>
         <aff-alternatives id="aff3">
            <aff xml:lang="sl">
               <label>3</label>
               <institution>Katedra za javno zdravje, Medicinska fakulteta, Univerza v Ljubljani, Ljubljana, Slovenija</institution>
            </aff>
            <aff xml:lang="en">
               <label>3</label>
               <institution>Chair of Public Health, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia</institution>
            </aff>
         </aff-alternatives>
         <author-notes>
            <fn fn-type="conflict" xml:lang="en">
               <p>The authors have declared that no competing interests exist.</p>
            </fn>
            <fn fn-type="conflict" xml:lang="sl">
               <p>Avtorji so izjavili, da ne obstajajo nobeni konkurenčni interesi.</p>
            </fn>
            <corresp id="corr">Barbara Artnik, e-mail: <email xlink:type="simple"/>
            </corresp>
         </author-notes>
         <pub-date pub-type="ppub">
            <month>12</month>
            <year>2019</year>
         </pub-date>
         <pub-date pub-type="epub">
            <month>12</month>
            <year>2019</year>
         </pub-date>
         <volume>88</volume>
         <issue>11–12</issue>
         <fpage>493</fpage>
         <lpage>508</lpage>
         <history>
            <date date-type="received">
               <day>11</day>
               <month>6</month>
               <year>2018</year>
            </date>
            <date date-type="accepted">
               <day>9</day>
               <month>7</month>
               <year>2019</year>
            </date>
         </history>
         <permissions>
            <copyright-statement xml:lang="en">Copyright © 2019, Slovenian Medical Association (SZD)</copyright-statement>
            <copyright-statement xml:lang="sl">© 2019, Slovensko zdravniško društvo (SZD)</copyright-statement>
            <copyright-year>2019</copyright-year>
            <copyright-holder xml:lang="en">Slovenian Medical Association (SZD)</copyright-holder>
            <copyright-holder xml:lang="sl">Slovensko zdravniško društvo (SZD)</copyright-holder>
            <license xlink:href="https://creativecommons.org/licenses/by-nc/4.0/"
                     xlink:type="simple"
                     xml:lang="en">
               <license-p>This is an open access article distributed under the terms of the
          <ext-link ext-link-type="uri"
                            xlink:href="https://creativecommons.org/licenses/by-nc/4.0/"
                            xlink:type="simple">Creative Commons Attribution-NonCommercial
            License</ext-link>, which permits unrestricted use, distribution, and
          reproduction in any medium, provided the original author and source are
          credited and only for non-commercial purposes. </license-p>
            </license>
            <license xlink:href="https://creativecommons.org/licenses/by-nc/4.0/"
                     xlink:type="simple"
                     xml:lang="sl">
               <license-p>To je članek z odprtim dostopom, ki ga lahko uporabite pod pogoji iz
          <ext-link ext-link-type="uri"
                            xlink:href="https://creativecommons.org/licenses/by-nc/4.0/"
                            xlink:type="simple">Creative Commons Priznanje avtorstva-Nekomercialno
            licence</ext-link>. ki dovoljuje distribucijo, predelavo ali
          prilagoditev, ter gradijo na njem, v nekomercialne namene, z navedbo avtorja
          in izvirnega dela.</license-p>
            </license>
         </permissions>
         <abstract xml:lang="sl">
            <title>Izvleček</title>
            <p>Izhodišče: Rak ustnega predela zajema področja ustnice, ustne votline in ustnega dela žrela in v Sloveniji predstavlja eno najpogostejših malignih bolezni. Namen raziskave je bil prikazati breme raka ustnega predela v tridesetletnem obdobju (1985–2014) v Sloveniji.</p>
            <p>Metode: Iz baze podatkov Registra raka Republike Slovenije smo pridobili podatke (incidenca, preživetje) o vseh primerih raka ustno-žrelnega predela (C00–C14) v letih 1985–2014. Analizo bremena raka ustnega predela smo pripravili za tri osnovna primarna mesta: ustnico (C00.0–2), ustno votlino (C00.3–9, C02.0–3 in C02.8–9, C03, C04, C05.0 in C05.8–9, C06) in ustni del žrela (C01, C02.4, C05.1–2, C09, C10). Časovne trende števila novih primerov raka po posameznem mestu smo prikazali v obliki deleža povprečne letne spremembe grobe incidenčne stopnje.</p>
            <p>Rezultati: Pridobili smo podatke o 9.442 primerih raka ustno-žrelnega predela za obdobje 1985–2014. V končno analizo smo vključili vse primere raka ustnega predela (N = 7.190). Med preiskovanci je bilo 83,4 % moških in 16,6 % žensk. Povprečna starost preiskovancev ob postavitvi diagnoze je bila 59,8 let ± 11,3. Največ primerov raka ustnice je v starostni skupini nad 80 let, največ primerov raka ustne votline in ustnega dela žrela pa v starostni skupini 55–59 let. Pri vseh treh skupinah raka je večji delež moških kot žensk. Največ primerov raka ustnice odkrijemo v omejenem stadiju, največ raka ustne votline in ustnega dela žrela v razširjenem stadiju. Najboljše je preživetje bolnikov z rakom ustnice, najslabše pri bolnikih z rakom ustnega dela žrela. Tridesetletni časovni trend raka prikazuje upadanje števila primerov raka ustnice, nasprotno pa število primerov raka ustne votline in ustnega dela žrela narašča.</p>
            <p>Zaključek: Rak ustnega predela je eden pomembnejših javnozdravstvenih, socialnih in ekonomskih problemov sodobne družbe. Zgodnje odkrivanje raka prispeva k izboljšanju preživetja in h kakovosti življenja bolnikov, zato je potrebno še posebno pozornost posvečati obvladovanju te bolezni.</p>
         </abstract>
         <trans-abstract xml:lang="en">
            <title>Abstract</title>
            <p>Background: Oral cancer is a collective name for lip cancer, oral cavity cancer and oropharyngeal cancer; it is one of the most prevalent malignancies in Slovenia. The aim of our study was to analyse the burden of oral cancer in a thirty-year period (1985–2014) in Slovenia.</p>
            <p>Methods: All new cases of oral and pharyngeal cancer (C00–C14) in Slovenia diagnosed between the years 1985–2014 were retrieved from the population based Slovenian Cancer Registry. The analysis of the burden of oral cancer was performed for three primary locations: lip (C00.0–2), oral cavity (C00.3–9, C02.0–3, C02.8–9, C03, C04, C05.0, C05.8–9, C06) and oropharynx (C01, C02.4, C05.1–2, C09, C10). Time trends in the incidence of oral cancer for three primary locations were presented with average annual percent changes in crude incidence rates.</p>
            <p>Results: 9,442 new cases of oral and pharyngeal cancer were observed between 1985 and 2014. Final analysis was performed for 7,190 new cases of lip, oral cavity and oropharyngeal cancer; 83.4 % of patients were men and 16.6 % were women. Average age of a patient at diagnosis was 59.8 years ± 11.3. The highest incidence of lip cancer was observed in 80+ age group, and the highest incidence of oral and oropharyngeal cancer was observed in 55–59 age group. The proportion of male patients was higher in all three cancer groups. The majority of new cases of lip cancer were diagnosed at a localised stage, whereas the majority of new cases of oral and oropharyngeal cancer were diagnosed at a regional stage. Survival rates were highest for patients with lip cancer and lowest for patients with oropharyngeal cancer. A thirty-year time trend showed that the incidence of lip cancer was decreasing, whereas the incidence rates of oral cavity cancer and oropharyngeal cancer were increasing.</p>
            <p>Conclusion: Oral cancer is one of the biggest public health and socioeconomic problems of modern society. Early detection of oral cancer improves survival rates and the quality of life of patients. It is necessary to pay attention to the burden of this disease and manage its prevention and control.</p>
         </trans-abstract>
         <kwd-group xml:lang="sl">
            <kwd>oral cancer</kwd>
            <kwd>cancer burden</kwd>
            <kwd>incidence</kwd>
            <kwd>time trend</kwd>
            <kwd>public health</kwd>
         </kwd-group>
         <kwd-group xml:lang="en">
            <kwd>rak ustnega predela</kwd>
            <kwd>breme raka</kwd>
            <kwd>incidenca</kwd>
            <kwd>časovni trend</kwd>
            <kwd>javno zdravje</kwd>
         </kwd-group>
      </article-meta>
   </front>
   <body>
      <sec id="s1" sec-type="Uvod">
         <label>1</label>
         <title>Uvod</title>
         <p>Rak ustnega predela zajema področja ustnice, ustne votline in ustnega dela žrela. Po pogostnosti je na 6. mestu med vsemi primeri raka na svetu. Letna incidenca znaša približno 400.000 primerov bolezni in močno variira med različnimi predeli sveta (<xref ref-type="bibr" rid="b1">1</xref>). Največja incidenca raka ustnega predela je na Šrilanki, v Indiji, Pakistanu, Bangladešu, na Madžarskem in v Franciji (<xref ref-type="bibr" rid="b2">2</xref>).</p>
         <p>Glavna etiološka dejavnika, odgovorna za kar 90 % primerov bolezni, sta tobak in alkohol, ostali dejavniki, povezani z nastankom raka, so še okužba s humanim papiloma virusom (HPV), kajenje marihuane, prehrana z nizko vsebnostjo sadja in zelenjave, slaba ustna higiena, socialna neenakost, izpostavljenost škodljivim kemikalijam na delovnem mestu, kronična travma ustne sluznice, UV-sevanje, imunosupresija (<xref ref-type="bibr" rid="b3">3</xref>-<xref ref-type="bibr" rid="b5">5</xref>). Raziskovalci v zadnjih letih vse več pozornosti namenjajo vlogi okužbe s HPV, saj so ugotovili velik delež HPV-pozitivnih primerov raka ustnega predela (v Evropi znaša 16,2 %) (<xref ref-type="bibr" rid="b6">6</xref>). Okužba je povezana z zgodnjim prvim spolnim odnosom, z večjim številom spolnih partnerjev, z izvajanjem oralne spolne prakse in z istospolnimi praksami (<xref ref-type="bibr" rid="b7">7</xref>-<xref ref-type="bibr" rid="b9">9</xref>).</p>
         <p>Za rakom ustnega predela pogosteje zbolevajo moški, starejši od 50 let, čeprav je zaradi sprememb v navadah kajenja in pitja alkoholnih pijač opaziti povečevanje deleža raka med ženskami. Leta 1950 je bilo razmerje zbolevanja med moškimi in ženskami 6:1, danes pa je 2:1 (<xref ref-type="bibr" rid="b4">4</xref>). Zaradi okužb s HPV raste incidenca v državah razvitega sveta med mladimi odraslimi, predvsem moškimi z višjim socialno-ekonomskim statusom, pri katerih ni prisotnih drugih dejavnikov tveganja za razvoj raka ali pa so prisotni le v manjši meri (<xref ref-type="bibr" rid="b10">10</xref>-<xref ref-type="bibr" rid="b12">12</xref>). Tipično rakavo spremembo predstavlja razjeda, ki se najpogosteje pojavlja na jeziku, ustnem dnu in licih. Do 70 % raka nastane iz predrakave spremembe (<xref ref-type="bibr" rid="b4">4</xref>,<xref ref-type="bibr" rid="b13">13</xref>). Histološko gre v 95 % za ploščatocelični karcinom (<xref ref-type="bibr" rid="b14">14</xref>,<xref ref-type="bibr" rid="b15">15</xref>). Čeprav je zgodnje postavljanje diagnoze sorazmerno enostavno, se večina primerov raka ustnega predela odkrije v razširjenem stadiju. Povprečno 5-letno preživetje je le okoli 50 %. V zadnjih desetletjih ostaja preživetje praktično nespremenjeno kljub napredku v diagnosticiranju in zdravljenju (<xref ref-type="bibr" rid="b4">4</xref>). V preglednem članku Lafaurie in sod. povzemajo, da je pri HPV-pozitivnih primerih raka ustnega predela napoved izida boljša kot pri HPV-negativnih primerih raka ustnega predela (<xref ref-type="bibr" rid="b16">16</xref>). O‘Rorke in sod. v sistematičnem pregledu in metaanalizi raka ustnega dela žrela ugotavljajo 52 % manjše tveganje za napredovanje bolezni, 63 % manjše tveganje za ponovitev bolezni in 53 % zmanjšano umrljivost (<xref ref-type="bibr" rid="b17">17</xref>). Njihove ugotovitve podpira tudi raziskava Strojana in sod., izvedena med letoma 2007 in 2008 na histopatoloških vzorcih bolnikov z rakom ustnega dela žrela v Sloveniji; okužba s HPV je neodvisni dejavnik zmanjšanega tveganja za napredovanje raka ustnega dela žrela in zmanjšano umrljivosti (<xref ref-type="bibr" rid="b11">11</xref>).</p>
         <p>Rak ustnega predela je tudi v Sloveniji ena najpogostejših malignih bolezni, saj predstavlja kar 54 % primerov raka glave in vratu, ki so pri moških na 5. mestu, pri ženskah na 14. mestu, skupno pa na 8. mestu po pogostnosti med vsemi primeri raka (<xref ref-type="bibr" rid="b18">18</xref>).</p>
         <p>Namen naše raziskave je bil prikazati breme raka ustnega predela v tridesetletnem obdobju (1985−2014) v Sloveniji. Preučevali smo osnovne epidemiološke kazalnike: incidenco in časovni trend glede na posamezno mesto ustnega predela, spol in starost bolnikov ter stadij ob postavitvi diagnoze, posebej pa še opazovano preživetje bolnikov v desetletnem obdobju (2005−2014).</p>
      </sec>
      <sec id="s2" sec-type="Metode">
         <label>2</label>
         <title>Metode</title>
         <sec id="s2.1" sec-type="Viri podatkov, preiskovanci in vključitvena merila">
            <label>2.1</label>
            <title>Viri podatkov, preiskovanci in vključitvena merila</title>
            <p>Iz baze podatkov Registra raka Republike Slovenije (RRRS) smo pridobili podatke o vseh primerih raka ustno-žrelnega predela (primeri raka glave in vratu brez primerov raka grla, nosne votline in obnosnih sinusov ter srednjega ušesa), v letih 1985–2014. Mesto raka je v RRRS definirano z deseto revizijo Mednarodne klasifikacije bolezni in sorodnih zdravstvenih problemov za statistično uporabo (MKB-10). Za našo analizo smo uporabili vse primere, ki so bili registrirani s kodami MKB-10 med C00 in C14. Dobili smo vpogled v anonimizirane podatke o:</p>
            <list>
               <list-item>
                  <label>•</label>
                  <p>spolu in starosti bolnika;</p>
               </list-item>
               <list-item>
                  <label>•</label>
                  <p>datumu postavitve diagnoze;</p>
               </list-item>
               <list-item>
                  <label>•</label>
                  <p>bolnišnici, v kateri so postavili diagnozo;</p>
               </list-item>
               <list-item>
                  <label>•</label>
                  <p>mestu in morfologiji;</p>
               </list-item>
               <list-item>
                  <label>•</label>
                  <p>stadiju raka;</p>
               </list-item>
               <list-item>
                  <label>•</label>
                  <p>vitalnem statusu in datumu smrti pri umrlih;</p>
               </list-item>
               <list-item>
                  <label>•</label>
                  <p>zdravstveni regiji, statistični regiji in upravni enoti kraja stalnega bivališča.</p>
               </list-item>
            </list>
            <p>Iz analize smo izključili vse preiskovance, ki so bili v RRRS prijavljeni, s katerim od primarnih mest C07, C08, C11, C12, C13, C14, kar pojasnjujemo v razpravljanju.</p>
            <p>Podatke o številu in starostni strukturi prebivalcev v tem obdobju smo pridobili iz podatkovnega portala Statističnega urada Republike Slovenije.</p>
         </sec>
         <sec id="s2.2" sec-type="Razdelitev raka ustnega predela">
            <label>2.2</label>
            <title>Razdelitev raka ustnega predela</title>
            <p>Razdelitev raka ustnega predela v literaturi ni jasno opredeljena. Več pozornosti temu problemu namenjamo v razpravljanju. V naši analizi smo za razdelitev uporabili MKB-10 in osmo izdajo Mednarodne klasifikacije rakavih bolezni (klasifikacija TNM) Mednarodne zveze za boj proti raku (UICC) (<xref ref-type="bibr" rid="b19">19</xref>). Primarna mesta ustno-žrelnega predela (C00–C14) smo razvrstili v naslednje skupine:</p>
            <list>
               <list-item>
                  <label>•</label>
                  <p>ustnica (C00.0–2);</p>
               </list-item>
               <list-item>
                  <label>•</label>
                  <p>ustna votlina (C00.3–9, C02.0–3 in C02.8–9, C03, C04, C05.0 in C05.8–9, C06);</p>
               </list-item>
               <list-item>
                  <label>•</label>
                  <p>ustni del žrela (C01, C02.4, C05.1–2, C09, C10);</p>
               </list-item>
               <list-item>
                  <label>•</label>
                  <p>žleze slinavke (C07, C08);</p>
               </list-item>
               <list-item>
                  <label>•</label>
                  <p>nosni del žrela (C11);</p>
               </list-item>
               <list-item>
                  <label>•</label>
                  <p>piriformni sinus (C12);</p>
               </list-item>
               <list-item>
                  <label>•</label>
                  <p>spodnji del žrela (C13);</p>
               </list-item>
               <list-item>
                  <label>•</label>
                  <p>ostalo (C14).</p>
               </list-item>
            </list>
            <p>Analizo smo pripravili za tri osnovna primarna mesta: za ustnico, ustno votlino in ustni del žrela. Razvrstitev posameznih anatomskih mest raka po MKB-10 v te tri mesta je predstavljena v <xref ref-type="table" rid="table1">Tabeli 1</xref>.</p>
         </sec>
         <sec id="s2.3" sec-type="Analiza podatkov">
            <label>2.3</label>
            <title>Analiza podatkov</title>
            <p>Za celotno tridesetletno obdobje (1985–2014) smo prikazali incidenco in deleže raka ustnega predela glede na posamezno mesto, spol, starost bolnika in stadij raka ob postavitvi diagnoze. Po mestih smo ocenili tudi tridesetletni časovni trend incidence. Natančnejši prikaz smo pripravili za zadnje desetletno obdobje (2005–2014). Podajamo incidenco, delež med vsemi primeri raka, kumulativno tveganje, grobo incidenčno stopnjo, starostno standardizirano stopnjo in ocenjene deleže letnih sprememb grobe in starostno standardizirane incidenčne stopnje za vsako posamezno mesto. Dodano je še opazovano preživetje bolnikov glede na posamezno mesto.</p>
            <p>Podatke smo analizirali z računalniškima programoma »Microsoft Excel 2016« in »IBM SPSS Statistics for Windows« (verzija 24.0) (<xref ref-type="bibr" rid="b20">20</xref>). Pri starostni standardizaciji incidenčnih stopenj smo uporabili direktno metodo standardizacije in svetovno standardno populacijo. Časovni trendi števila novih primerov raka po posameznem mestu so bili analizirani v programu »Joinpoint Regression Program« (verzija 4.1.1; Bethesda, MD: Statistical Research and Applications Branch, National Cancer Institute, October 2014) (<xref ref-type="bibr" rid="b21">21</xref>). Pri tem smo trende prikazali v obliki deleža povprečne letne spremembe (<italic>angl.</italic> average annual percent change, AAPC) grobe incidenčne stopnje. Pri vsakem AAPC so bile izračunane tudi vrednosti 95-odstotnega intervala zaupanja. Meja statistične značilnosti trendov je bila postavljena na p &lt; 0,05.</p>
         </sec>
      </sec>
      <sec id="s3" sec-type="Rezultati">
         <label>3</label>
         <title>Rezultati</title>
         <p>Pridobili smo podatke o vseh primerih raka ustno-žrelnega predela (C00–C14; N = 9.442; N – število novih primerov raka) za obdobje 1985–2014. V končno analizo smo vključili vse primere raka ustnega predela (C00–C06, C09 in C10; N = 7.190). Razlika v številu primerov raka (N = 2.252) predstavlja tiste primere raka ustno-žrelnega predela, ki smo jih izključili iz analize (C07, C08, C11–C14).</p>
         <p>Incidence in deleže po posameznih mestih smo prikazali v <xref ref-type="table" rid="table1">Tabeli 1</xref>. Med preiskovanci je bilo 5.994 (83,4 %) moških in 1.197 (16,6 %) žensk. Povprečna starost preiskovancev ob postavitvi diagnoze je bila 59,8 let ± 11,3; moških 58,9 let ± 10,5 in žensk 64,0 let ± 14,1.</p>
         <table-wrap position="anchor" id="table1">
            <label>Tabela 1:</label>
            <caption>
               <p> Osnovno breme raka ustnega predela v letih 1985−2014.</p>
            </caption>
            <table>
               <colgroup>
                  <col/>
                  <col/>
                  <col/>
                  <col/>
               </colgroup>
               <thead>
                  <tr>
                     <th>Mesto</th>
                     <th>MKB-10</th>
                     <th>Incidenca (n)</th>
                     <th>Delež glede na mesto (%)</th>
                  </tr>
               </thead>
               <tbody>
                  <tr>
                     <td rowspan="4">Ustnica</td>
                     <td>C00.1 – zunanja spodnja ustnica</td>
                     <td align="right">697</td>
                     <td align="right">90,0</td>
                  </tr>
                  <tr>
                     <td>C00.0 – zunanja zgornja ustnica</td>
                     <td align="right">71</td>
                     <td align="right">9,2</td>
                  </tr>
                  <tr>
                     <td>C00.2 – zunanja ustnica, neopredeljena</td>
                     <td align="right">6</td>
                     <td align="right">0,8</td>
                  </tr>
                  <tr>
                     <th content-type="table-subhead">SKUPAJ</th>
                     <th align="right" content-type="table-subhead">774</th>
                     <th align="right" content-type="table-subhead">100,0</th>
                  </tr>
                  <tr>
                     <td rowspan="28">Ustna votlina</td>
                     <td>C04.9 – ustno dno, neopredeljeno</td>
                     <td align="right">667</td>
                     <td align="right">23,2</td>
                  </tr>
                  <tr>
                     <td>C02.1 – rob jezika</td>
                     <td align="right">446</td>
                     <td align="right">15,5</td>
                  </tr>
                  <tr>
                     <td>C06.2 – retromolarno področje</td>
                     <td align="right">190</td>
                     <td align="right">6,6</td>
                  </tr>
                  <tr>
                     <td>C04.1 – lateralno ustno dno</td>
                     <td align="right">174</td>
                     <td align="right">6,0</td>
                  </tr>
                  <tr>
                     <td>C02.9 – jezik, neopredeljen</td>
                     <td align="right">169</td>
                     <td align="right">5,9</td>
                  </tr>
                  <tr>
                     <td>C02.3 – sprednji dve tretjini jezika, brez opredelitve mesta</td>
                     <td align="right">153</td>
                     <td align="right">5,3</td>
                  </tr>
                  <tr>
                     <td>C04.8 – preraščajoča sprememba v ustnem dnu</td>
                     <td align="right">149</td>
                     <td align="right">5,2</td>
                  </tr>
                  <tr>
                     <td>C06.9 – usta, neopredeljena</td>
                     <td align="right">140</td>
                     <td align="right">4.9</td>
                  </tr>
                  <tr>
                     <td>C03.1 – spodnja dlesen</td>
                     <td align="right">132</td>
                     <td align="right">4,6</td>
                  </tr>
                  <tr>
                     <td>C04.0 – sprednje ustno dno</td>
                     <td align="right">115</td>
                     <td align="right">4,0</td>
                  </tr>
                  <tr>
                     <td>C03.0 – zgornja dlesen</td>
                     <td align="right">86</td>
                     <td align="right">3,0</td>
                  </tr>
                  <tr>
                     <td>C06.0 – bukalna sluznica</td>
                     <td align="right">86</td>
                     <td align="right">3,0</td>
                  </tr>
                  <tr>
                     <td>C02.8 – preraščajoča sprememba na jeziku</td>
                     <td align="right">72</td>
                     <td align="right">2,5</td>
                  </tr>
                  <tr>
                     <td>C05.8 – preraščajoča sprememba na nebu</td>
                     <td align="right">59</td>
                     <td align="right">2,0</td>
                  </tr>
                  <tr>
                     <td>C05.0 – trdo nebo</td>
                     <td align="right">54</td>
                     <td align="right">1,9</td>
                  </tr>
                  <tr>
                     <td>C00.9 – ustnica, neopredeljena</td>
                     <td align="right">37</td>
                     <td align="right">1,3</td>
                  </tr>
                  <tr>
                     <td>C06.1 – vestibulum ust</td>
                     <td align="right">36</td>
                     <td align="right">1,3</td>
                  </tr>
                  <tr>
                     <td>C02.2 – ventralna površina jezika</td>
                     <td align="right">23</td>
                     <td align="right">0,8</td>
                  </tr>
                  <tr>
                     <td>C00.4 – spodnja ustnica, notranji del</td>
                     <td align="right">19</td>
                     <td align="right">0,7</td>
                  </tr>
                  <tr>
                     <td>C05.9 – nebo, neopredeljeno</td>
                     <td align="right">18</td>
                     <td align="right">0,6</td>
                  </tr>
                  <tr>
                     <td>C02.0 – dorzalna površina jezika</td>
                     <td align="right">15</td>
                     <td align="right">0,5</td>
                  </tr>
                  <tr>
                     <td>C06.8 – preraščajoča sprememba na drugih in neopredeljenih ustnih delih</td>
                     <td align="right">14</td>
                     <td align="right">0,5</td>
                  </tr>
                  <tr>
                     <td>C03.9 – dlesen, neopredeljena</td>
                     <td align="right">8</td>
                     <td align="right">0,3</td>
                  </tr>
                  <tr>
                     <td>C00.5 – ustnica, neopredeljena, notranji del</td>
                     <td align="right">3</td>
                     <td align="right">0,1</td>
                  </tr>
                  <tr>
                     <td>C00.6 – komisura ustnic</td>
                     <td align="right">3</td>
                     <td align="right">0,1</td>
                  </tr>
                  <tr>
                     <td>C00.3 – zgornja ustnica, notranji del</td>
                     <td align="right">3</td>
                     <td align="right">0,1</td>
                  </tr>
                  <tr>
                     <td>C00.8 – preraščajoča sprememba na ustnici</td>
                     <td align="right">2</td>
                     <td align="right">0,1</td>
                  </tr>
                  <tr>
                     <th content-type="table-subhead">SKUPAJ</th>
                     <th align="right" content-type="table-subhead">2873</th>
                     <th align="right" content-type="table-subhead">100,0</th>
                  </tr>
                  <tr>
                     <td rowspan="16">Ustni del žrela</td>
                     <td>C10.9 – orofarinks, neopredeljen</td>
                     <td align="right">902</td>
                     <td align="right">25,5</td>
                  </tr>
                  <tr>
                     <td>C01 – baza jezika</td>
                     <td align="right">505</td>
                     <td align="right">14,2</td>
                  </tr>
                  <tr>
                     <td>C09.9 – tonzila, neopredeljena</td>
                     <td align="right">462</td>
                     <td align="right">13,0</td>
                  </tr>
                  <tr>
                     <td>C10.8 – preraščajoča sprememba v orofarinksu</td>
                     <td align="right">424</td>
                     <td align="right">12,0</td>
                  </tr>
                  <tr>
                     <td>C09.0 – tonzilarna loža</td>
                     <td align="right">284</td>
                     <td align="right">8,0</td>
                  </tr>
                  <tr>
                     <td>C05.1 – mehko nebo</td>
                     <td align="right">197</td>
                     <td align="right">5,6</td>
                  </tr>
                  <tr>
                     <td>C10.0 – valekula</td>
                     <td align="right">148</td>
                     <td align="right">4,2</td>
                  </tr>
                  <tr>
                     <td>C10.2 – stranska stena orofarinksa</td>
                     <td align="right">147</td>
                     <td align="right">4,1</td>
                  </tr>
                  <tr>
                     <td>C09.1 – tonzilarni lok</td>
                     <td align="right">136</td>
                     <td align="right">3,8</td>
                  </tr>
                  <tr>
                     <td>C05.2 – uvula</td>
                     <td align="right">119</td>
                     <td align="right">3,4</td>
                  </tr>
                  <tr>
                     <td>C09.8 – preraščajoča sprememba na tonzili</td>
                     <td align="right">84</td>
                     <td align="right">2,4</td>
                  </tr>
                  <tr>
                     <td>C10.3 – zadnja stena orfarinksa</td>
                     <td align="right">82</td>
                     <td align="right">2,3</td>
                  </tr>
                  <tr>
                     <td>C10.1 – sprednja površina epiglotisa (poklopca)</td>
                     <td align="right">46</td>
                     <td align="right">1,3</td>
                  </tr>
                  <tr>
                     <td>C02.4 – jezična tonzila</td>
                     <td align="right">6</td>
                     <td align="right">0,2</td>
                  </tr>
                  <tr>
                     <td>C10.4 – branhialna reža</td>
                     <td align="right">1</td>
                     <td align="right">0,0</td>
                  </tr>
                  <tr>
                     <th content-type="table-subhead">SKUPAJ</th>
                     <th align="right" content-type="table-subhead">3543</th>
                     <th align="right" content-type="table-subhead">100,0</th>
                  </tr>
                  <tr>
                     <th>Skupaj</th>
                     <th/>
                     <th align="right">7190</th>
                     <th/>
                  </tr>
               </tbody>
            </table>
         </table-wrap>
         <sec id="s3.1"
              sec-type="Incidenca in preživetje bolnikov z rakom ustnega predela">
            <label>3.1</label>
            <title>Incidenca in preživetje bolnikov z rakom ustnega predela</title>
            <p>V <xref ref-type="table" rid="table2">Tabeli 2</xref> smo prikazali osnovne epidemiološke podatke o raku ustnega predela. V podobnih tabelah (<italic>angl.</italic> »cancer fact sheet«, CFS) podatke o raku prikazuje tudi spletni portal SLORA (<xref ref-type="bibr" rid="b18">18</xref>). Pri moških je bilo število novih primerov raka ustne votline v zadnjem desetletju skoraj trikrat večje kot pri ženskah, število novih primerov raka ustnega dela žrela pa skoraj šestkrat večje kot pri ženskah. Rak ustne votline predstavlja slab odstotek med vsemi primeri raka (s kožnim rakom in brez njega), rak ustnega dela žrela pa dobra dva odstotka med vsemi primeri raka (s kožnim rakom in brez njega). Tveganje, da bodo moški, rojeni v Sloveniji leta 2014, do svojega 75. leta starosti zboleli za rakom ustnice, je petkrat večje kot pri ženskah; tveganje, da bodo zboleli za rakom ustne votline, je skoraj trikrat večje kot pri ženskah; tveganje, da bodo zboleli za rakom ustnega dela žrela, je šestkrat večje kot pri ženskah.</p>
            <table-wrap position="anchor" id="table2">
               <label>Tabela 2:</label>
               <caption>
                  <p> Incidenca in tveganje za nastanek raka ustnega predelav letih 2005−2014.</p>
               </caption>
               <table>
                  <colgroup>
                     <col/>
                     <col/>
                     <col/>
                     <col/>
                     <col/>
                     <col/>
                     <col/>
                     <col/>
                     <col/>
                     <col/>
                  </colgroup>
                  <tbody>
                     <tr>
                        <th rowspan="2">Incidenca <break/>(povprečje v letih 2005–2014)</th>
                        <th colspan="3">Ustnica</th>
                        <th colspan="3">Ustna votlina</th>
                        <th colspan="3">Ustni del žrela</th>
                     </tr>
                     <tr>
                        <th>Moški</th>
                        <th>Ženske</th>
                        <th>Skupaj</th>
                        <th>Moški</th>
                        <th>Ženske</th>
                        <th>Skupaj</th>
                        <th>Moški</th>
                        <th>Ženske</th>
                        <th>Skupaj</th>
                     </tr>
                     <tr>
                        <td>Število novih primerov v enem letu</td>
                        <td align="right">16</td>
                        <td align="right">7</td>
                        <td align="right">23</td>
                        <td align="right">73</td>
                        <td align="right">28</td>
                        <td align="right">101</td>
                        <td align="right">109</td>
                        <td align="right">19</td>
                        <td align="right">128</td>
                     </tr>
                     <tr>
                        <td>Odstotek med vsemi primeri raka (%)</td>
                        <td align="right">0,2</td>
                        <td align="right">0,1</td>
                        <td align="right">0,2</td>
                        <td align="right">1,06</td>
                        <td align="right">0,48</td>
                        <td align="right">0,79</td>
                        <td align="right">1,6</td>
                        <td align="right">0,3</td>
                        <td align="right">1,0</td>
                     </tr>
                     <tr>
                        <td>Odstotek med vsemi primeri raka, razen kožnega raka (%)</td>
                        <td align="right">0,3</td>
                        <td align="right">0,1</td>
                        <td align="right">0,2</td>
                        <td align="right">1,25</td>
                        <td align="right">0,58</td>
                        <td align="right">0,95</td>
                        <td align="right">1,9</td>
                        <td align="right">0,4</td>
                        <td align="right">2,2</td>
                     </tr>
                     <tr>
                        <td>Tveganje raka do 75. leta starosti (KT) (%)</td>
                        <td align="right">0,10</td>
                        <td align="right">0,02</td>
                        <td align="right">0,06</td>
                        <td align="right">0,54</td>
                        <td align="right">0,17</td>
                        <td align="right">0,35</td>
                        <td align="right">0,81</td>
                        <td align="right">0,13</td>
                        <td align="right">0,46</td>
                     </tr>
                     <tr>
                        <td>Groba incidenčna stopnja na 100.000 prebivalcev</td>
                        <td align="right">1,6</td>
                        <td align="right">0,8</td>
                        <td align="right">1,1</td>
                        <td align="right">7,3</td>
                        <td align="right">2,7</td>
                        <td align="right">4,9</td>
                        <td align="right">10,9</td>
                        <td align="right">1,9</td>
                        <td align="right">6,3</td>
                     </tr>
                     <tr>
                        <td>Starostno standardizirana incidenčna stopnja (SSS) na 100.000 prebivalcev (W)</td>
                        <td align="right">0,9</td>
                        <td align="right">0,2</td>
                        <td align="right">0,5</td>
                        <td align="right">4,5</td>
                        <td align="right">1,5</td>
                        <td align="right">3,0</td>
                        <td align="right">6,8</td>
                        <td align="right">1,1</td>
                        <td align="right">3,8</td>
                     </tr>
                     <tr>
                        <td>Ocenjeni delež letne spremembe grobe incidenčne stopnje zadnjih 10 let (%)</td>
                        <td align="right">-2,5</td>
                        <td align="right">-12,5</td>
                        <td align="right">-5,2</td>
                        <td align="right">-0,9</td>
                        <td align="right">0,3</td>
                        <td align="right">-0,6</td>
                        <td align="right">1,7</td>
                        <td align="right">0,3</td>
                        <td align="right">2,0</td>
                     </tr>
                     <tr>
                        <td>Ocenjeni delež letne spremembe SSS zadnjih 10 let (%)</td>
                        <td align="right">-4,6</td>
                        <td align="right">-16,5</td>
                        <td align="right">-7,0</td>
                        <td align="right">-2,0</td>
                        <td align="right">-1,8</td>
                        <td align="right">-1,9</td>
                        <td align="right">-0,9</td>
                        <td align="right">2,9</td>
                        <td align="right">0,6</td>
                     </tr>
                  </tbody>
               </table>
            </table-wrap>
            <p>Razporejanje zbolelih po starosti ob diagnozi je podobno pri raku ustne votline in ustnega dela žrela, drugačne značilnosti pa ima starostna struktura bolnikov z rakom ustnice (<xref ref-type="fig" rid="fig1">Slika 1</xref>).</p>
            <fig position="anchor" id="fig1">
               <label>Slika 1:</label>
               <caption>
                  <p> Število novih primerov raka ustnega predela glede na mesto in starost bolnikov ob postavitvi diagnoze v letih 1985−2014.</p>
               </caption>
               <p>
                  <graphic xlink:href="2845-web-resources/image/zdravvestn-2845-sl-01.png"/>
               </p>
            </fig>
            <p>Največ primerov raka ustnice je v starostni skupini nad 80 let, največ primerov raka ustne votline in ustnega dela žrela pa v starostni skupini 55–59 let. Primerov raka ustne votline pred 30. letom starosti je bilo 19, primerov raka ustnice ali ustnega dela žrela pred to starostjo ni bilo zabeleženih. Najmlajši bolnik z rakom ustne votline je bil star 19 let.</p>
            <p>Pri vseh treh skupinah raka je večji delež moških kot žensk. Največ primerov raka ustnice odkrijemo v omejenem stadiju, največ primerov raka ustne votline in ustnega dela žrela pa v razširjenem stadiju. Najboljše je preživetje bolnikov z rakom ustnice, najslabše je pri bolnikih z rakom ustnega dela žrela. Povprečno 1-/3-/5-letno preživetje bolnikov z rakom ustnega dela žrela se v zadnjih desetih letih glede na obdobje 1985–2014 ni občutno izboljšalo in je še vedno nizko (<xref ref-type="table" rid="table3">Tabela 3</xref>).</p>
            <table-wrap position="anchor" id="table3">
               <label>Tabela 3:</label>
               <caption>
                  <p> Novi primeri raka ustnega predela glede na spol in stadij v letih 1985−2014 ter opazovano preživetje bolnikov v letih 2005−2014.</p>
               </caption>
               <table>
                  <colgroup>
                     <col/>
                     <col/>
                     <col/>
                     <col/>
                     <col/>
                     <col/>
                     <col/>
                     <col/>
                  </colgroup>
                  <tbody>
                     <tr>
                        <th align="right" rowspan="2" colspan="2">Mesto</th>
                        <th align="center" colspan="2">Ustnica</th>
                        <th align="center" colspan="2">Ustna votlina</th>
                        <th align="center" colspan="2">Ustni del žrela</th>
                     </tr>
                     <tr>
                        <th>N</th>
                        <th align="center">%</th>
                        <th align="center">N</th>
                        <th align="center">%</th>
                        <th align="center">N</th>
                        <th align="center">%</th>
                     </tr>
                     <tr>
                        <td rowspan="2">Spol</td>
                        <td>M</td>
                        <td align="right">574</td>
                        <td align="right">74,2</td>
                        <td align="right">2291</td>
                        <td align="right">79,7</td>
                        <td align="right">3129</td>
                        <td align="right">88,3</td>
                     </tr>
                     <tr>
                        <td>Ž</td>
                        <td align="right">200</td>
                        <td align="right">25,8</td>
                        <td align="right">582</td>
                        <td align="right">20,3</td>
                        <td align="right">414</td>
                        <td align="right">11,7</td>
                     </tr>
                     <tr>
                        <td rowspan="4">Stadij</td>
                        <td>omejen</td>
                        <td align="right">708</td>
                        <td align="right">91,5</td>
                        <td align="right">991</td>
                        <td align="right">34,5</td>
                        <td align="right">541</td>
                        <td align="right">15,3</td>
                     </tr>
                     <tr>
                        <td>razširjen</td>
                        <td align="right">54</td>
                        <td align="right">7,0</td>
                        <td align="right">1783</td>
                        <td align="right">62,1</td>
                        <td align="right">2857</td>
                        <td align="right">80,6</td>
                     </tr>
                     <tr>
                        <td>razsejan</td>
                        <td align="right">1</td>
                        <td align="right">0,1</td>
                        <td align="right">46</td>
                        <td align="right">1,6</td>
                        <td align="right">104</td>
                        <td align="right">2,9</td>
                     </tr>
                     <tr>
                        <td>ni podatka</td>
                        <td align="right">11</td>
                        <td align="right">1,4</td>
                        <td align="right">53</td>
                        <td align="right">1,8</td>
                        <td align="right">41</td>
                        <td align="right">1,2</td>
                     </tr>
                     <tr>
                        <td rowspan="4">Opazovano preživetje</td>
                        <td>1-letno</td>
                        <td align="right">/</td>
                        <td align="right">94</td>
                        <td align="right">/</td>
                        <td align="right">78</td>
                        <td align="right">/</td>
                        <td align="right">68</td>
                     </tr>
                     <tr>
                        <td>3-letno</td>
                        <td align="right">/</td>
                        <td align="right">79</td>
                        <td align="right">/</td>
                        <td align="right">55</td>
                        <td align="right">/</td>
                        <td align="right">46</td>
                     </tr>
                     <tr>
                        <td>5-letno</td>
                        <td align="right">/</td>
                        <td align="right">70</td>
                        <td align="right">/</td>
                        <td align="right">45</td>
                        <td align="right">/</td>
                        <td align="right">37</td>
                     </tr>
                     <tr>
                        <td>10-letno</td>
                        <td align="right">/</td>
                        <td align="right">43</td>
                        <td align="right">/</td>
                        <td align="right">33</td>
                        <td align="right">/</td>
                        <td align="right">25</td>
                     </tr>
                  </tbody>
               </table>
            </table-wrap>
         </sec>
         <sec id="s3.2"
              sec-type="Časovni trend raka ustnice, ustne votline in ustnega dela žrela v letih 1985–2014">
            <label>3.2</label>
            <title>Časovni trend raka ustnice, ustne votline in ustnega dela žrela v letih 1985–2014</title>
            <p>Tridesetletni časovni trend raka prikazuje upadanje števila primerov raka ustnice, nasprotno pa število primerov raka ustne votline in ustnega dela žrela narašča (<xref ref-type="fig" rid="fig2">Slika 2</xref>). V tem obdobju ni prišlo do nenadnih sprememb v padanju ali naraščanju incidence.</p>
            <fig position="anchor" id="fig2">
               <label>Slika 2:</label>
               <caption>
                  <p> Časovni trend raka ustnega predela glede na mesto v letih 1985−2014.</p>
               </caption>
               <p>
                  <graphic xlink:href="2845-web-resources/image/zdravvestn-2845-sl-02.png"/>
               </p>
               <p>* AAPC – ocenjeni delež povprečne letne spremembe grobe incidenčne stopnje, 1985–2014.</p>
            </fig>
         </sec>
      </sec>
      <sec id="s4" sec-type="Razpravljanje">
         <label>4</label>
         <title>Razpravljanje</title>
         <sec id="s4.1" sec-type="Breme raka ustnega predela">
            <label>4.1</label>
            <title>Breme raka ustnega predela</title>
            <p>Rezultati naše raziskave kažejo, da je število novih primerov raka v Sloveniji glede na posamezno mesto pričakovano. Največ raka ustnice je v starostni skupini nad 80 let. Vzrok temu so dolgotrajni učinki sončnih žarkov in pridruženi vplivi drugih dejavnikov tveganja (<xref ref-type="bibr" rid="b22">22</xref>). Rak ustnice se največkrat pojavi na zunanji spodnji ustnici, ki je bolj kot zgornja ustnica izpostavljena sončnim žarkom, učinkom alkohola in vročega dima ob kajenju tobaka. Pomemben dejavnik tveganja je tudi zdravljenje z imunosupresivi (<xref ref-type="bibr" rid="b23">23</xref>). Za rakom ustne votline in ustnega dela žrela v povprečju zbolevajo mlajše osebe, saj se učinki rabe tobaka in alkohola, ki sta najpogostejša etiološka dejavnika (<xref ref-type="bibr" rid="b4">4</xref>), ne seštevajo, temveč potencirajo (<xref ref-type="bibr" rid="b3">3</xref>).</p>
            <p>Leta 2007 je Mednarodna agencija za raziskave raka (<italic>angl.</italic> International Agency for Research on Cancer, IARC) uvrstila HPV v skupino karcinogenih agensov (<xref ref-type="bibr" rid="b24">24</xref>). Dokazana je bila povezava med okužbo s HPV in rakom ustnega dela žrela (<xref ref-type="bibr" rid="b25">25</xref>,<xref ref-type="bibr" rid="b26">26</xref>), zato se v zadnjem času vse večji vpliv na zbolevanje mlajše populacije za rakom ustnega dela žrela pripisuje tudi okužbi s HPV (<xref ref-type="bibr" rid="b3">3</xref>,<xref ref-type="bibr" rid="b27">27</xref>). Pripisljivi delež raka (<italic>angl.</italic> population attributable fraction, PAF) se izračuna na podlagi pogostnosti okužbe v rakavem tkivu in relativnega tveganja za okužbo (<xref ref-type="bibr" rid="b28">28</xref>). To pomeni število novih primerov raka, ki bi jih lahko preprečili, če bi se izognili okužbi s HPV ali če bi okužbo s HPV uspešno pozdravili. Deleža raka ustne votline in ustnega dela žrela, ki ju lahko pripišemo okužbi s HPV, zanašata 4,3 % oziroma 30,8 % (<xref ref-type="bibr" rid="b29">29</xref>,<xref ref-type="bibr" rid="b30">30</xref>). V naši raziskavi smo tako kot Haeggblom in sod. v njihovem sistematičnem pregledu literature o prevalenci HPV pri raku ustnega dela žrela (<xref ref-type="bibr" rid="b31">31</xref>) ugotovili, da je novih primerov raka ustnega dela žrela na mesto v limfoepitelnem tkivu (baza jezika, C01; tonzile, C09) več kot na ostalih mestih ustnega dela žrela. Haeggblom in sod. so pogosteje našli HPV v limfoepitelnem tkivu kot v nelimfoepitelnem tkivu ustnega dela žrela (<xref ref-type="bibr" rid="b31">31</xref>). O vplivu dejavnikov tveganja na razvoj raka ustnega predela lahko iz podatkov, ki smo jih uporabili v raziskavi, le sklepamo, ne moremo pa ugotavljati njihove povezanosti. V RRRS namreč podatki o kadilskem statusu, pitju alkohola in HPV-statusu bolnikov niso zabeleženi (<xref ref-type="bibr" rid="b11">11</xref>).</p>
            <p>Glede zbolevanja po spolu rezultati raziskave kažejo, da za rakom ustnega predela pogosteje zbolevajo moški. Rak ustnice se pojavlja trikrat pogosteje, rak ustne votline štirikrat pogosteje ter rak ustnega dela žrela sedemkrat pogosteje kot pri ženskah. Delež omejenega stadija bolezni je najvišji pri raku ustnice, pri raku ustne votline in ustnega dela žrela pa prevladuje delež razširjenega stadija bolezni, s čimer je povezano tudi slabše preživetje bolnikov. Vzrokov za to je več. Dostopnost posameznih mest ustnega predela za klinični pregled in samopregledovanje sta pri posamezniku različna. K nastanku raka prispevajo tudi neredni obiski zobozdravnika, lahko pa tudi nenatančno in neredno pregledovanje ustnega predela ob obisku izbranega zobozdravnika ali osebnega zdravnika.</p>
            <p>V zadnjem desetletju groba incidenčna stopnja in starostno standardizirana stopnja raka ustnega predela upadata, razen pri raku ustne votline pri ženskah in raku ustnega dela žrela pri obeh spolih, pri katerih naraščata.</p>
            <p>Pri poročanju o incidenci raka ustnega predela smo upoštevali izračun s kožnim rakom in brez njega. Domnevamo, da je v Sloveniji – in tudi v drugih evropskih populacijskih registrih raka – manj popolna registracija nemelanomskega kožnega raka in tistih malignomov, ki se zdravijo samo ambulantno (<xref ref-type="bibr" rid="b32">32</xref>). V Sloveniji je v letu 2014 nemelanomski kožni rak predstavljal 18 % vseh novih primerov raka (<xref ref-type="bibr" rid="b33">33</xref>). V nekaterih državah registri raka nimajo dostopa do ambulantno ugotovljenih (in zdravljenih) nemelanomskih primerov kožnega raka, zato jih ne registrirajo. To je razlog, da se nemelanomski kožni rak izključuje iz mednarodnih primerjav (<xref ref-type="bibr" rid="b34">34</xref>).</p>
         </sec>
         <sec id="s4.2" sec-type="Časovni trend raka ustnega predela">
            <label>4.2</label>
            <title>Časovni trend raka ustnega predela</title>
            <p>V analizi časovnih trendov smo želeli prikazati čim daljše obdobje. Podatki o incidenci in prevalenci so v RRRS dostopni od 1950 naprej, o umrljivosti in preživetju pa od 1985 naprej. Leto 1985 je tako služilo kot začetek naše tridesetletne analize (<xref ref-type="bibr" rid="b35">35</xref>).</p>
            <p>Število novih primerov raka ustnice upada. To je odraz uspešnega ozaveščanja o škodljivosti izpostavljanja sončnim žarkom in zaščiti pred UV-sevanjem (<xref ref-type="bibr" rid="b36">36</xref>,<xref ref-type="bibr" rid="b37">37</xref>) ter ukrepov na področju tobačne in alkoholne politike (<xref ref-type="bibr" rid="b38">38</xref>,<xref ref-type="bibr" rid="b39">39</xref>). Preventivo na tem področju je kljub temu potrebno še krepiti. Nasprotno pa število novih primerov raka ustne votline in ustnega dela žrela narašča. Le priporočila in ozaveščanje o škodljivih učinkih alkohola in kajenja tobaka pri padanju incidence ne zadoščajo. Spreminjajoči se trendi incidence raka ustne votline in ustnega dela žrela v slovenski populaciji so verjetno posledica spreminjajoče se izpostavljenosti dejavnikom tveganja v zadnjih desetletjih (<xref ref-type="bibr" rid="b11">11</xref>). Delež kadilcev se je od leta 1978 s 36 % (<xref ref-type="bibr" rid="b40">40</xref>) zmanjšal na 22,6 % leta 2012 (pri moških kadilcih upada, pri ženskah od leta 2001 stagnira) (<xref ref-type="bibr" rid="b41">41</xref>). Pitje čezmernih količin alkohola upada, a ostaja nad povprečjem EU, v porastu je visokotvegano opijanje nekajkrat letno in od 1- do 3-krat mesečno (<xref ref-type="bibr" rid="b42">42</xref>,<xref ref-type="bibr" rid="b43">43</xref>). Naraščajoči trend incidence raka ustnega dela žrela v veliki meri pripisujemo okužbi s HPV (<xref ref-type="bibr" rid="b25">25</xref>,<xref ref-type="bibr" rid="b26">26</xref>). Upada tudi delež oseb, ki uživajo sadje in zelenjavo, ki sta zaščitna dejavnika proti raku (<xref ref-type="bibr" rid="b44">44</xref>,<xref ref-type="bibr" rid="b45">45</xref>).</p>
            <p>Neposredna primerjava trenda, ugotovljenega v naši raziskavi, z drugimi raziskavami ni možna, saj v teh raziskavah spremljajo večletne trende raka za celotni ustno-žrelni predel (C00–C14). Po podatkih EUCAN 2012 je bila v Sloveniji incidenca 12,6/100.000 prebivalcev. V Severni Evropi je incidenca največja na Danskem (13,0/100.000 prebivalcev), v Zahodni Evropi v Franciji (15,0/100.000 prebivalcev), v Južni Evropi na Portugalskem (15,4/100.000 prebivalcev), v Vzhodni Evropi na Madžarskem (23,3/100.000 prebivalcev). Na Madžarskem je tudi največja incidenca v Evropi, in sicer skoraj devetkrat večja kot na Cipru, kjer je najmanjša (2,7/100.000 prebivalcev) (<xref ref-type="bibr" rid="b27">27</xref>). V Veliki Britaniji opažajo povečevanje bremena raka ustne votline, v jugovzhodni Angliji v letih 1987–2006 predvsem raka jezika, baze jezika, dlesni in neba (<xref ref-type="bibr" rid="b46">46</xref>). Na Nizozemskem se je v letih 1991–2010 incidenca raka ustne votline povečevala, prav tako umrljivost, preživetje bolnikov pa se je izboljševalo. Rak ustne votline je po pogostnosti prehitel raka grla (<xref ref-type="bibr" rid="b47">47</xref>). Na Danskem se je v letih 1980–2012 incidenca raka ustne votline in ustnega dela žrela povečevala (<xref ref-type="bibr" rid="b48">48</xref>). V ZDA je bilo v letih 1975–2004 zaznati zmanjševanje incidence in umrljivosti, a povečevanje obeh znotraj določenih demografskih skupin (<xref ref-type="bibr" rid="b49">49</xref>). Na Novi Zelandiji in v Queenslandu v Avstraliji so v letih 1982–2010 poročali o povečevanju incidence raka ustnega dela žrela, medtem ko je incidenca raka ustne votline ostala nespremenjena oziroma se je pri moških v Queenslandu zmanjšala (<xref ref-type="bibr" rid="b50">50</xref>).</p>
         </sec>
         <sec id="s4.3"
              sec-type="Nedosledno poročanje o raku ustnega predela v Sloveniji">
            <label>4.3</label>
            <title>Nedosledno poročanje o raku ustnega predela v Sloveniji</title>
            <p>Iz naše analize je razvidno, da v Sloveniji k osnovnemu bremenu raka ustnega predela največ prispeva rak ustnega dela žrela. Ta predel je za klinični pregled težje dostopen in tudi bolniki sami opazijo ali začutijo spremembo na sluznici šele, ko se ji pridružijo resnejši simptomi (bolečina, oteklina, krvavenje iz rane, težave pri žvečenju in požiranju) (<xref ref-type="bibr" rid="b4">4</xref>).</p>
            <p>Rak ustne votline se najpogosteje (69 %) pojavlja na ustnem dnu in jeziku, saj sta ti dve mesti najbolj izpostavljeni vplivom glavnih dejavnikov tveganja. Polovica primerov raka ustne votline (N = 1.335) je opredeljena kot »preraščajoča lezija« ali »lokacija, neopredeljeno«. To pomeni, da je bil rak odkrit pozno, v razširjenem stadiju, zato je natančen izvor težje določiti. Poleg tega primarno mesto ni natančno opisano in je v RRRS registrirana s kategorijo »lokacija, neopredeljeno«. Neobjavljeni rezultati prikazujejo, da je med letoma 1994 in 1995 zaznati skokovit porast opredelitev »preraščajoča lezija« in upad opredelitev »lokacija, neopredeljeno«. Razlog za to je sprememba beleženja novih primerov raka po klasifikaciji MKB-10, ki je nasledila MKB-8, v kateri so bile »preraščajoče lezije« in »lokacija, neopredeljeno« skupna kategorija. Za nazaj vnesenih podatkov RRRS ne popravlja.</p>
            <p>Prijavljanje raka je v Sloveniji obvezno in z zakonom predpisano že od ustanovitve RRRS na Onkološkem inštitutu (OI) Ljubljana leta 1950. Vse bolnišnice v Republiki Sloveniji, javni zdravstveni zavodi ter druge pravne in fizične osebe, ki opravljajo zdravstveno dejavnost, morajo predpisane podatke posredovati sproti na Prijavnici rakave bolezni. Poleg prikaza bremena raka v državi so ti podatki izhodišče za ocenjevanje uspešnosti onkološke preventive, diagnosticiranja, zdravljenja, rehabilitacije, paliativne oskrbe in načrtovanje zmogljivosti in sredstev za obvladovanje rakavih bolezni.</p>
            <p>Zdravnik, ki prijavlja bolezen na Prijavnici rakave bolezni, izpolni oziroma opredeli primarno mesto raka opisno, vendar ne z določanjem kategorije MKB-10. Ti podatki se prenesejo v register, pri čemer se mora mesto šifrirati s kategorijo in podkategorijo MKB-10. Odločanje o tem, v katero podkategorijo umestiti raka, je velikokrat težavno, saj je pogosto opis mesta na prijavnici pomanjkljiv. Katera kategorija po MKB-10 za vnos v register najbolj ustreza določenemu nejasnemu opisu mesta, je določeno z mednarodnimi in v RRRS dogovorjenimi pravili. Register veliko časa porabi za poizvedbe o nepopolno zapisanih ali celo neustreznih podatkih na prijavnici (<xref ref-type="bibr" rid="b33">33</xref>,<xref ref-type="bibr" rid="b51">51</xref>).</p>
         </sec>
         <sec id="s4.4" sec-type="Priporočila za opredelitev raka ustnega predela">
            <label>4.4</label>
            <title>Priporočila za opredelitev raka ustnega predela</title>
            <p>Opredelitev raka ustnega predela tudi v literaturi ni enotna (<xref ref-type="bibr" rid="b52">52</xref>). V učbenikih, strokovnih člankih in na spletnih straneh tujih združenj (National Cancer Institute (<xref ref-type="bibr" rid="b53">53</xref>), American Joint Committe on Cancer (<xref ref-type="bibr" rid="b54">54</xref>), American Head &amp; Neck Society (<xref ref-type="bibr" rid="b55">55</xref>), American Cancer Society (<xref ref-type="bibr" rid="b56">56</xref>), Cancer Research UK (<xref ref-type="bibr" rid="b57">57</xref>)) ni jasnih definicij. Zasledimo različne razdelitve. Največ neskladij najdemo pri razvrščanju raka ustnice, jezične tonzile in mehkega neba k raku ustne votline.</p>
            <p>Za težavno opredeljevanje raka ustnega predela obstaja več razlogov. Klinično se s patologijo tega področja ukvarjajo zobozdravniki, zdravniki specialisti družinske medicine, maksilofacialni in oralni kirurgi, otorinolaringologi idr. Anatomsko je področje zelo razgibano in jasnih prehodov med strukturami ni. Embriološko nastanejo ustnica, ustna votlina in žrelo iz prvotne ustne votline (ektoderm) in pračrevesja (endoderm), ki sta do 8. embrionalnega tedna ločena z žrelno membrano. Tako razvoj ustnice, lica, trdega neba in ventralnega dela jezika poteka iz ektoderma, mehko nebo, žrelo in dorzalni del jezika pa se razvijejo iz endoderma (<xref ref-type="bibr" rid="b58">58</xref>). Poleg tega so dejavniki tveganja za nastanek raka ustnega predela številni (<xref ref-type="bibr" rid="b3">3</xref>).</p>
            <p>Pri razdelitvi raka ustnega predela (<xref ref-type="table" rid="table1">Tabela 1</xref>) smo poleg mednarodnih klasifikacij, navedenih v metodah, uporabili tudi sodobne članke s področja definiranja raka ustne votline (<xref ref-type="bibr" rid="b2">2</xref>,<xref ref-type="bibr" rid="b3">3</xref>,<xref ref-type="bibr" rid="b52">52</xref>). Tapia in Goldberg (<xref ref-type="bibr" rid="b52">52</xref>) izpostavljata neenotno opredelitev definicije raka ustnega predela in njegovega mesta. Njuno ugotovitev sta v naslednjih letih podprla Radöi in Luce (<xref ref-type="bibr" rid="b3">3</xref>) s sistematičnim pregledom 102 člankov iz različnih držav (vseh celin), v katerem so navedene definicije ustne votline posameznih avtorjev. Razdelitve, navedene v njunem članku (<xref ref-type="bibr" rid="b3">3</xref>), smo nadgradili z ločeno opredelitvijo ustnice (kožna meja in rdečina). To je pomembno, ker se pri raku ustnice dejavniki tveganja in starost bolnikov ob postavitvi diagnoze razlikujejo od primerov raka ustne votline in ustnega dela žrela (<xref ref-type="bibr" rid="b22">22</xref>). Jezično tonzilo in mehko nebo smo razvrstili k ustnemu delu žrela. Za potrebe primerjalnih študij lahko ta tri mesta priključimo ustni votlini. Kategoriji C07 in C08 smo izločili iz analize, saj večina rakov žlez slinavk ni ploščatoceličnih karcinomov, poleg tega se etiološki dejavniki razlikujejo od etioloških dejavnikov raka ustnega predela (<xref ref-type="bibr" rid="b59">59</xref>,<xref ref-type="bibr" rid="b60">60</xref>). Kategorijo C11 smo prav tako izločili iz analize zaradi razlikovanja v etioloških dejavnikih (<xref ref-type="bibr" rid="b61">61</xref>,<xref ref-type="bibr" rid="b62">62</xref>). Kategoriji C12 in C13 smo izločili iz analize zaradi njune anatomske umeščenosti, ki ne spada k ustnemu predelu. Kategorijo C14 smo izločili iz analize, čeprav vključuje maligne neoplazme drugih in slabo opredeljenih mest na ustnici, v ustni votlini in žrelu (farinks, Waldeyerjev obroč, preraščajoče spremembe na ustnici, v ustni votlini in žrelu). Teh primerov je bilo v 30 letih opredeljenih le 23.</p>
         </sec>
         <sec id="s4.5"
              sec-type="Priporočila za preprečevanje in zgodnejše odkrivanje raka ustnega predela">
            <label>4.5</label>
            <title>Priporočila za preprečevanje in zgodnejše odkrivanje raka ustnega predela</title>
            <p>Zobozdravniki in zdravniki moramo biti pozorni na morebitne spremembe ustnega predela, še posebej pri ogroženi populaciji, ki pogosteje zboleva za rakom ustnega predela. Najbolj so ogroženi moški, starejši od 50 let, z nižjim socialno-ekonomskim statusom, ki čezmerno uživajo alkohol in so kadilci. Zaradi spreminjajočih se trendov obolevnosti za rakom ustnega predela in vse pomembnejše vloge okužbe s HPV (<xref ref-type="bibr" rid="b25">25</xref>,<xref ref-type="bibr" rid="b26">26</xref>) je potrebno več pozornosti nameniti tudi mlajši populaciji. Priporočamo svetovanje o varni spolnosti in možni dodatni zaščiti pred okužbo s HPV. Cepljenje proti okužbi s HPV je bilo v Sloveniji uvedeno v letu 2009 in je neobvezno. Brezplačno cepljenje je omogočeno deklicam v starosti 11–12 let, saj je učinkovitost cepiva največja, če se opravi, preden ima oseba prvi spolni odnos. Cepivo je dostopno tudi dečkom in odraslim ženskam (<xref ref-type="bibr" rid="b63">63</xref>). Učinkovitost cepljenja proti okužbi s HPV pri obeh spolih v preventivi raka ustnega predela, v nasprotju z učinkovitostjo cepljenja v preventivi raka v anogenitalnem področju, še ni dokazana (<xref ref-type="bibr" rid="b64">64</xref>-<xref ref-type="bibr" rid="b68">68</xref>). Kljub uvedenemu cepljenju sta najpomembnejša preventiva pred okužbo s HPV, ki bi lahko pripeljala do razvoja raka ustnega predela, varna spolnost in preventivni pregledi pri zobozdravniku/zdravniku.</p>
            <p>Razmerje med številom zobozdravnikov in številom prebivalcev Slovenije (1/1.370) omogoča, da se vsaka oseba stomatološko pregleda enkrat letno. Ob tem zobozdravnik pregleda celotni ustni predel, ne glede na to, ali oseba navaja težave ali ne (<xref ref-type="bibr" rid="b69">69</xref>). Ljudi je potrebno opolnomočiti, da prevzamejo odgovornost za lastno skrb za ustno zdravje. Razložiti jim moramo, da na nekatere dejavnike tveganja, kot sta spol in starost, nimamo vpliva, medtem ko so drugi dejavniki tveganja spremenljivi (raba tobaka in alkohola, neuravnotežena prehrana, slaba ustna higiena, izpostavljanje sončnim žarkom, okužba s HPV, nižji socialno-ekonomski status). Ključnega pomena so redni obiski pri zobozdravniku ne glede na odsotnost morebitnih težav in samopregledovanje ustnega predela, ki ga priporočamo enkrat mesečno. Pot obravnave bolnika z rakom ustnega predela od pojava prvih težav do postopkov diagnosticiranja ni natančno opredeljena. V primeru opazne spremembe (spremembe mehkih tkiv, bele ali rdeče lise ali rane, ki se ne zacelijo v dveh tednih), mora oseba takoj obiskati zobozdravnika oziroma jo zobozdravnik napoti (če je potrebno) na specialistični pregled ali jo pogosteje vabi na kontrolne preglede.</p>
            <p>Okoli 80 % bolnikov z rakom ustne votline na zdravljenje napotijo zobozdravniki (<xref ref-type="bibr" rid="b69">69</xref>). Izbrani osebni zdravniki, specialisti družinske medicine, prav tako prevzemajo pomembno vlogo pri odkrivanju predrakavih in rakavih sprememb ustnega predela, saj jih ljudje obiščejo večkrat kot izbrane zobozdravnike. Del klinične preiskave v ambulanti družinske medicine je tudi osnovni pregled ustne votline (<xref ref-type="bibr" rid="b70">70</xref>). Smernice obravnave bolnika od postavitve diagnoze dalje so natančno navedene in prosto dostopne na spletni strani OI (<xref ref-type="bibr" rid="b71">71</xref>).</p>
            <p>Stalno strokovno izpopolnjevanje zobozdravnikov in zdravnikov je nujno za nadgrajevanje znanja o raku ustnega predela. S pridobljenim znanjem je potrebno ozaveščati ljudi in javnost o pomenu preventive in zgodnjega odkrivanja raka ustnega predela, saj bomo le tako vzpostavili kontinuiteto preventivnega delovanja na tem področju. Poleg splošnih nasvetov za zmanjšanje ogroženosti z rakom (<xref ref-type="bibr" rid="b72">72</xref>) moramo poudariti tudi promocijo ustnega zdravja za ozaveščanje o pomenu ustnega zdravja za splošno zdravje in o dejavnikih tveganja za nastanek raka ustnega predela.</p>
         </sec>
      </sec>
      <sec id="s5" sec-type="Zaključek">
         <label>5</label>
         <title>Zaključek</title>
         <p>Po natančnem pregledu literature in po ostalih nam dostopnih podatkih v slovenskem prostoru doslej ni bilo splošno uveljavljene opredelitve ustnega predela. Pri analizi podatkov se je izkazalo tudi, da je opredeljevanje točnega primarnega mesta raka na Prijavnici rakave bolezni pomanjkljivo, kar lahko privede do nenatančnih epidemioloških podatkov o raku. Zato smo predstavili razdelitev raka ustnega predela, ki je primerna za slovenski prostor glede na etiološke dejavnike ter klinično in epidemiološko obravnavo tega raka. Za epidemiološko spremljanje bremena raka ustnega predela v prihodnje priporočamo prikazano razdelitev na mesto: ustnica, ustna votlina in ustni del žrela.</p>
         <p>Rak ustnega predela je eden pomembnejših javnozdravstvenih, socialnih in ekonomskih problemov sodobne družbe. V našem prispevku smo poudarili problem poznega odkrivanja tega raka kljub dostopnosti ustnega predela za klinični pregled. Zgodnje odkrivanje raka prispeva k izboljšanju preživetja in h kakovosti življenja bolnikov, zato je potrebno še posebno pozornost posvečati obvladovanju te bolezni.</p>
      </sec>
   </body>
   <back>
      <ack>
         <label>6</label>
         <title>Zahvala</title>
         <p>Avtorice se zahvaljujemo RRRS, še posebej Katarini Lokar, prof. zdr. vzg., in dr. Tini Žagar, univ. dipl. fiz., za sodelovanje pri izvedbi raziskave in statistični obdelavi podatkov.</p>
      </ack>
      <ref-list>
         <ref id="b1">
            <label>1. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Warnakulasuriya</surname>
                     <given-names>S</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Global epidemiology of oral and oropharyngeal cancer</article-title>. 
                    <source>Oral Oncol</source>. 
                    <year>2009</year>
                    <month>Apr-May</month>;
                    <volume>45</volume>(
                    <issue>4-5</issue>):
                    <fpage>309</fpage>–
                    <lpage>16</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.oraloncology.2008.06.002</pub-id>
                    <pub-id pub-id-type="pmid">18804401</pub-id>
                    <issn>1368-8375</issn>
                </mixed-citation>
         </ref>
         <ref id="b2">
            <label>2. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Montero</surname>
                     <given-names>PH</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Patel</surname>
                     <given-names>SG</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Cancer of the oral cavity</article-title>. 
                    <source>Surg Oncol Clin N Am</source>. 
                    <year>2015</year>
                    <month>Jul</month>;
                    <volume>24</volume>(
                    <issue>3</issue>):
                    <fpage>491</fpage>–
                    <lpage>508</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.soc.2015.03.006</pub-id>
                    <pub-id pub-id-type="pmid">25979396</pub-id>
                    <issn>1055-3207</issn>
                </mixed-citation>
         </ref>
         <ref id="b3">
            <label>3. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Radoï</surname>
                     <given-names>L</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Luce</surname>
                     <given-names>D</given-names>
                  </name>
                    </person-group>. 
                    <article-title>A review of risk factors for oral cavity cancer: the importance of a standardized case definition</article-title>. 
                    <source>Community Dent Oral Epidemiol</source>. 
                    <year>2013</year>
                    <month>Apr</month>;
                    <volume>41</volume>(
                    <issue>2</issue>):
                    <fpage>97</fpage>–
                    <lpage>109</lpage>. 
                   <pub-id pub-id-type="doi">10.1111/j.1600-0528.2012.00710.x</pub-id>
                   <pub-id pub-id-type="pmid">22882534</pub-id>
                    <issn>0301-5661</issn>
                </mixed-citation>
         </ref>
         <ref id="b4">
            <label>4. </label>
            <mixed-citation publication-type="book">
                 <person-group person-group-type="editor">
                 <name name-style="western">
                     <surname>Benzian</surname>
                     <given-names>M</given-names>
                  </name>,
                   <name name-style="western">
                     <surname>Williams</surname>
                     <given-names>D</given-names>
                  </name> 
                   </person-group>.
                   <source>The Oral Health Atlas</source>.
                   <edition>2nd ed</edition>. 
                   <publisher-loc>Geneva</publisher-loc>:
                   <publisher-name>FDI World Dental Federation</publisher-name>;
                   <year>2015</year>. pp. 
                   <fpage>6</fpage>–
                   <lpage>69</lpage>.
                   (<series>The challenge of oral disease. A call for global action</series>).
                </mixed-citation>
         </ref>
         <ref id="b5">
            <label>5. </label>
            <mixed-citation publication-type="web-page">
                    <person-group person-group-type="author">
                     <collab>International Agency for Research on Cancer</collab> 
                    </person-group>. 
                    <source>WHO: International Agency for Research on Cancer. A digital manual for the early diagnosis of oral neoplasia. Squamous cell carcinoma</source>.
                    <year>2019</year>.
                    <date-in-citation content-type="access-date">[cited 2019 Mar 22]</date-in-citation> 
                    <comment>Available from:<uri>https://screening.iarc.fr/atlasoral_list.php?cat=B2&amp;lang=1</uri>
               </comment>.                
            </mixed-citation>
         </ref>
         <ref id="b6">
            <label>6. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Yete</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>D’Souza</surname>
                     <given-names>W</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Saranath</surname>
                     <given-names>D</given-names>
                  </name>
                    </person-group>. 
                    <article-title>High-risk human papillomavirus in oral cancer: clinical implications</article-title>. 
                    <source>Oncology</source>. 
                    <year>2018</year>;
                    <volume>94</volume>(
                    <issue>3</issue>):
                    <fpage>133</fpage>–
                    <lpage>41</lpage>. 
                    <pub-id pub-id-type="doi">10.1159/000485322</pub-id>
                    <pub-id pub-id-type="pmid">29241220</pub-id>
                    <issn>0030-2414</issn>
                </mixed-citation>
         </ref>
         <ref id="b7">
            <label>7. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Tay</surname>
                     <given-names>SK</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Oon</surname>
                     <given-names>LL</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Prevalence of cervical human papillomavirus infection in healthy women is related to sexual behaviours and educational level: a cross-sectional study</article-title>. 
                    <source>Int J STD AIDS</source>. 
                    <year>2014</year>
                    <month>Dec</month>;
                    <volume>25</volume>(
                    <issue>14</issue>):
                    <fpage>1013</fpage>–
                    <lpage>21</lpage>. 
                    <pub-id pub-id-type="doi">10.1177/0956462414528315</pub-id>
                    <pub-id pub-id-type="pmid">24648316</pub-id>
                    <issn>0956-4624</issn>
                </mixed-citation>
         </ref>
         <ref id="b8">
            <label>8. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Shah</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Malik</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Garg</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Mair</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Nair</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Chaturvedi</surname>
                     <given-names>P</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Oral sex and human papilloma virus-related head and neck squamous cell cancer: a review of the literature</article-title>. 
                    <source>Postgrad Med J</source>. 
                    <year>2017</year>
                    <month>Nov</month>;
                    <volume>93</volume>(
                    <issue>1105</issue>):
                    <fpage>704</fpage>–
                    <lpage>9</lpage>. 
                    <pub-id pub-id-type="doi">10.1136/postgradmedj-2016-134603</pub-id>
                    <pub-id pub-id-type="pmid">28778951</pub-id>
                    <issn>0032-5473</issn>
                </mixed-citation>
         </ref>
         <ref id="b9">
            <label>9. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Gillison</surname>
                     <given-names>ML</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Chaturvedi</surname>
                     <given-names>AK</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Anderson</surname>
                     <given-names>WF</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Fakhry</surname>
                     <given-names>C</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma</article-title>. 
                    <source>J Clin Oncol</source>. 
                    <year>2015</year>
                    <month>Oct</month>;
                    <volume>33</volume>(
                    <issue>29</issue>):
                    <fpage>3235</fpage>–
                    <lpage>42</lpage>. 
                    <pub-id pub-id-type="doi">10.1200/JCO.2015.61.6995</pub-id>
                    <pub-id pub-id-type="pmid">26351338</pub-id>
                    <issn>0732-183X</issn>
                </mixed-citation>
         </ref>
         <ref id="b10">
            <label>10. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Chaturvedi</surname>
                     <given-names>AK</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Engels</surname>
                     <given-names>EA</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Anderson</surname>
                     <given-names>WF</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Gillison</surname>
                     <given-names>ML</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States</article-title>. 
                    <source>J Clin Oncol</source>. 
                    <year>2008</year>
                    <month>Feb</month>;
                    <volume>26</volume>(
                    <issue>4</issue>):
                    <fpage>612</fpage>–
                    <lpage>9</lpage>. 
                    <pub-id pub-id-type="doi">10.1200/JCO.2007.14.1713</pub-id>
                    <pub-id pub-id-type="pmid">18235120</pub-id>
                    <issn>0732-183X</issn>
                </mixed-citation>
         </ref>
         <ref id="b11">
            <label>11. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Strojan</surname>
                     <given-names>P</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Zadnik</surname>
                     <given-names>V</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Šifrer</surname>
                     <given-names>R</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Lanišnik</surname>
                     <given-names>B</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Didanović</surname>
                     <given-names>V</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Jereb</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Incidence trends in head and neck squamous cell carcinoma in Slovenia, 1983-2009: role of human papillomavirus infection</article-title>. 
                    <source>Eur Arch Otorhinolaryngol</source>. 
                    <year>2015</year>
                    <month>Dec</month>;
                    <volume>272</volume>(
                    <issue>12</issue>):
                    <fpage>3805</fpage>–
                    <lpage>14</lpage>. 
                    <pub-id pub-id-type="doi">10.1007/s00405-014-3459-7</pub-id>
                    <pub-id pub-id-type="pmid">25542247</pub-id>
                    <issn>0937-4477</issn>
                </mixed-citation>
         </ref>
         <ref id="b12">
            <label>12. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Deschler</surname>
                     <given-names>DG</given-names>
                  </name>, 
                       <name name-style="western">
                     <surname>Richmon</surname>
                     <given-names>JD</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Khariwala</surname>
                     <given-names>SS</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Ferris</surname>
                     <given-names>RL</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Wang</surname>
                     <given-names>MB</given-names>
                  </name>
                    </person-group>. 
                    <article-title>The “new” head and neck cancer patient-young, nonsmoker, nondrinker, and HPV positive: evaluation</article-title>. 
                    <source>Otolaryngol Head Neck Surg</source>. 
                    <year>2014</year>
                    <month>Sep</month>;
                    <volume>151</volume>(
                    <issue>3</issue>):
                    <fpage>375</fpage>–
                    <lpage>80</lpage>. 
                    <pub-id pub-id-type="doi">10.1177/0194599814538605</pub-id>
                    <pub-id pub-id-type="pmid">24925311</pub-id>
                    <issn>0194-5998</issn>
                </mixed-citation>
         </ref>
         <ref id="b13">
            <label>13. </label>
            <mixed-citation publication-type="web-page">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Patel</surname>
                     <given-names>R</given-names>
                  </name>
                    </person-group>. 
                    <article-title>The state of oral health in Europe</article-title>. 
                    <year>2012</year>.                     
                    <date-in-citation content-type="access-date">[cited 2019 March 22]</date-in-citation>.
                    <comment>Available from:<uri>http://www.oralhealthplatform.eu/our-work/the-state-of-oral-health-in-europe/</uri>
               </comment>.
                </mixed-citation>
         </ref>
         <ref id="b14">
            <label>14. </label>
            <mixed-citation publication-type="book-chapter">
                    <chapter-title>Ustna votlina</chapter-title>.
                    <comment>In</comment>: 
                    <person-group person-group-type="editor">
                    <name name-style="western">
                     <surname>Primic-Žakelj</surname>
                     <given-names>M</given-names>
                  </name>, 
                    <name name-style="western">
                     <surname>Zadnik</surname>
                     <given-names>V</given-names>
                  </name>, 
                    <name name-style="western">
                     <surname>Žagar</surname>
                     <given-names>T</given-names>
                  </name>, 
                    <name name-style="western">
                     <surname>Zakotnik</surname>
                     <given-names>B</given-names>
                  </name>
                        <role>eds</role>,
                    </person-group>.
                    <source>Preživetje bolnikov z rakom, zbolelih v letih 1991–2005 v Sloveniji</source>. 
                    <publisher-loc>Ljubljana</publisher-loc>:
                    <publisher-name>Onkološki inštitut Ljubljana</publisher-name>;
                    <year>2009</year>. pp.
                    <fpage>36</fpage>-
                    <lpage>43</lpage>.    
                </mixed-citation>
         </ref>
         <ref id="b15">
            <label>15. </label>
            <mixed-citation publication-type="book-chapter">
                 <chapter-title>Ustno žrelo </chapter-title>.
                <comment>In</comment>: 
                <person-group person-group-type="editor">
                    <name name-style="western">
                     <surname>Primic-Žakelj</surname>
                     <given-names>M</given-names>
                  </name>, 
                    <name name-style="western">
                     <surname>Zadnik</surname>
                     <given-names>V</given-names>
                  </name>, 
                    <name name-style="western">
                     <surname>Žagar</surname>
                     <given-names>T</given-names>
                  </name>, 
                    <name name-style="western">
                     <surname>Zakotnik</surname>
                     <given-names>B</given-names>
                  </name>
                  <role>eds</role>
                </person-group>.  
                    <source>Preživetje bolnikov z rakom, zbolelih v letih 1991–2005 v Sloveniji</source>. 
                    <publisher-loc>Ljubljana</publisher-loc>:
                    <publisher-name>Onkološki inštitut Ljubljana</publisher-name>;
                    <year>2009</year>. pp.
                    <fpage>28</fpage>-
                    <lpage>35</lpage>.       
                </mixed-citation>
         </ref>
         <ref id="b16">
            <label>16. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Lafaurie</surname>
                     <given-names>GI</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Perdomo</surname>
                     <given-names>SJ</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Buenahora</surname>
                     <given-names>MR</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Amaya</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Díaz-Báez</surname>
                     <given-names>D</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Human papilloma virus: an etiological and prognostic factor for oral cancer?</article-title>
                    <source>J Investig Clin Dent</source>. 
                    <year>2018</year>
                    <month>May</month>;
                    <volume>9</volume>(
                    <issue>2</issue>):
                    <fpage>e12313</fpage>. 
                    <pub-id pub-id-type="doi">10.1111/jicd.12313</pub-id>
                    <pub-id pub-id-type="pmid">29322686</pub-id>
                    <issn>2041-1618</issn>
                </mixed-citation>
         </ref>
         <ref id="b17">
            <label>17. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>O’Rorke</surname>
                     <given-names>MA</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Ellison</surname>
                     <given-names>MV</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Murray</surname>
                     <given-names>LJ</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Moran</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>James</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Anderson</surname>
                     <given-names>LA</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Human papillomavirus related head and neck cancer survival: a systematic review and meta-analysis</article-title>. 
                    <source>Oral Oncol</source>. 
                    <year>2012</year>
                    <month>Dec</month>;
                    <volume>48</volume>(
                    <issue>12</issue>):
                    <fpage>1191</fpage>–
                    <lpage>201</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.oraloncology.2012.06.019</pub-id>
                    <pub-id pub-id-type="pmid">22841677</pub-id>
                    <issn>1368-8375</issn>
                </mixed-citation>
         </ref>
         <ref id="b18">
            <label>18.	</label>
            <mixed-citation publication-type="web-page">
                    <person-group person-group-type="author">
                        <collab>slora.si</collab>
                    </person-group>. 
                    <article-title>Slovenija : Slovenija in rak; Osnovni epidemiološki podatki o raku. Glava in vrat (C00–C14, C30–C32)</article-title>.
                    <year>2018</year>.
                    <date-in-citation content-type="access-date" iso-8601-date="2018-03-16">[cited 2018 Mar 16]</date-in-citation>.
                    <comment>Available from:<uri>http://www.slora.si/c/document_library/get_file?uuid=e320aca2-d106-4478-8f0e-125255c5792e&amp;groupId=11561</uri>
               </comment>                   
                </mixed-citation>
         </ref>
         <ref id="b19">
            <label>19. </label>
            <mixed-citation publication-type="book">
                    <person-group person-group-type="editor">
                        <name name-style="western">
                     <surname>Brierley</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Gospodarowicz</surname>
                     <given-names>MK</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Witterkind</surname>
                     <given-names>Ch</given-names>
                  </name>
                        <role>eds</role>
                    </person-group>.
                    <source>TNM Classification of Malignant Tumors</source>.
                    <edition>Eighth edition</edition>. 
                    <publisher-loc>Oxford, UK, Hoboken, NY</publisher-loc>:
                    <publisher-name>John Wiley &amp; Sons</publisher-name>;
                    <year>2017</year>.                   
                </mixed-citation>
         </ref>
         <ref id="b20">
            <label>20. </label>
            <mixed-citation publication-type="book">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Corp</surname>
                     <given-names>IB</given-names>
                  </name>
                    </person-group>.                     
                    <source>IBM SPSS Statistics for Windows, Version 24.0</source>. 
                    <publisher-loc>Armonk, NY</publisher-loc>:
                    <publisher-name>IBM Corp.</publisher-name>;                     
                    <year>2016</year>.
                </mixed-citation>
         </ref>
         <ref id="b21">
            <label>21. </label>
            <mixed-citation publication-type="book">
                    <person-group person-group-type="author">
                        <collab>Joinpoint Regression Program</collab>       
                    </person-group>. 
                    <source>Statistical Methodology and Applications Branch, Surveillance Research Program</source>.
                    <publisher-loc>Bethesda, MD</publisher-loc>:
                    <publisher-name>National Cancer Institute</publisher-name>;
                    <year>2014</year>.
                </mixed-citation>
         </ref>
         <ref id="b22">
            <label>22. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Moore</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Johnson</surname>
                     <given-names>N</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Pierce</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Wilson</surname>
                     <given-names>D</given-names>
                  </name>
                    </person-group>. 
                    <article-title>The epidemiology of lip cancer: a review of global incidence and aetiology</article-title>. 
                    <source>Oral Dis</source>. 
                    <year>1999</year>
                    <month>Jul</month>;
                    <volume>5</volume>(
                    <issue>3</issue>):
                    <fpage>185</fpage>–
                    <lpage>95</lpage>. 
                    <pub-id pub-id-type="doi">10.1111/j.1601-0825.1999.tb00300.x</pub-id>
                    <pub-id pub-id-type="pmid">10483063</pub-id>
                    <issn>1354-523X</issn>
                </mixed-citation>
         </ref>
         <ref id="b23">
            <label>23.	</label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bota</surname>
                     <given-names>JP</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Lyons</surname>
                     <given-names>AB</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Carroll</surname>
                     <given-names>BT</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Squamous cell carcinoma of the lip–a review of squamous cell carcinogenesis of the mucosal and cutaneous junction</article-title>. 
                    <source>Dermatol Surg</source>. 
                    <year>2017</year>
                    <month>Apr</month>;
                    <volume>43</volume>(
                    <issue>4</issue>):
                    <fpage>494</fpage>–
                    <lpage>506</lpage>. 
                    <pub-id pub-id-type="doi">10.1097/DSS.0000000000001020</pub-id>
                    <pub-id pub-id-type="pmid">28157733</pub-id>
                    <issn>1076-0512</issn>
                </mixed-citation>
         </ref>
         <ref id="b24">
            <label>24. </label>
            <mixed-citation publication-type="book">
                    <person-group person-group-type="author">
                        <collab>World Health Organization, International Agency for Research on Cancer</collab>.
                    </person-group>. 
                    <source>Human papillomaviruses</source>.
                    <publisher-loc>Lyon</publisher-loc>: 
                    <publisher-name>IARC</publisher-name>; 
                    <year>2007</year>. pp. 
                    <fpage>223</fpage>–
                    <lpage>76</lpage>.
                    <series>IARC monographs on the evaluation of carcinogenic risks to humans; vol. 90</series>.
                </mixed-citation>
         </ref>
         <ref id="b25">
            <label>25. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Gillison</surname>
                     <given-names>ML</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Koch</surname>
                     <given-names>WM</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Capone</surname>
                     <given-names>RB</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Spafford</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Westra</surname>
                     <given-names>WH</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Wu</surname>
                     <given-names>L</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Evidence for a causal association between human papillomavirus and a subset of head and neck cancers</article-title>. 
                    <source>J Natl Cancer Inst</source>. 
                    <year>2000</year>
                    <month>May</month>;
                    <volume>92</volume>(
                    <issue>9</issue>):
                    <fpage>709</fpage>–
                    <lpage>20</lpage>. 
                    <pub-id pub-id-type="doi">10.1093/jnci/92.9.709</pub-id>
                    <pub-id pub-id-type="pmid">10793107</pub-id>
                    <issn>0027-8874</issn>
                </mixed-citation>
         </ref>
         <ref id="b26">
            <label>26. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Chaturvedi</surname>
                     <given-names>AK</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Engels</surname>
                     <given-names>EA</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Pfeiffer</surname>
                     <given-names>RM</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Hernandez</surname>
                     <given-names>BY</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Xiao</surname>
                     <given-names>W</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Kim</surname>
                     <given-names>E</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Human papillomavirus and rising oropharyngeal cancer incidence in the United States</article-title>. 
                    <source>J Clin Oncol</source>. 
                    <year>2011</year>
                    <month>Nov</month>;
                    <volume>29</volume>(
                    <issue>32</issue>):
                    <fpage>4294</fpage>–
                    <lpage>301</lpage>. 
                    <pub-id pub-id-type="doi">10.1200/JCO.2011.36.4596</pub-id>
                    <pub-id pub-id-type="pmid">21969503</pub-id>
                    <issn>0732-183X</issn>
                </mixed-citation>
         </ref>
         <ref id="b27">
            <label>27. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Diz</surname>
                     <given-names>P</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Meleti</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Diniz-Freitas</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Vescovi</surname>
                     <given-names>P</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Warnakulasuriya</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Johnson</surname>
                     <given-names>NW</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Oral and pharyngeal cancer in Europe</article-title>. 
                    <source>Transl Res Oral Oncol</source>. 
                    <year>2017</year>;
                    <volume>2</volume>:
                    <fpage>1</fpage>–
                    <lpage>13</lpage>.
                    <issn>2057-178X</issn>
                </mixed-citation>
         </ref>
         <ref id="b28">
            <label>28. </label>
            <mixed-citation publication-type="webpage">
                <source>WHO | Metrics: Population Attributable Fraction (PAF)</source>.
                <comment>Available from:<uri>https://www.who.int/healthinfo/global_burden_disease/metrics_paf/en/</uri>
               </comment>.
                </mixed-citation>
         </ref>
         <ref id="b29">
            <label>29. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Plummer</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>de Martel</surname>
                     <given-names>C</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Vignat</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Ferlay</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bray</surname>
                     <given-names>F</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Franceschi</surname>
                     <given-names>S</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Global burden of cancers attributable to infections in 2012: a synthetic analysis</article-title>. 
                    <source>Lancet Glob Health</source>. 
                    <year>2016</year>
                    <month>Sep</month>;
                    <volume>4</volume>(
                    <issue>9</issue>):
                    <fpage>e609</fpage>–
                    <lpage>16</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/S2214-109X(16)30143-7</pub-id>
                    <pub-id pub-id-type="pmid">27470177</pub-id>
                    <issn>2214-109X</issn>
                </mixed-citation>
         </ref>
         <ref id="b30">
            <label>30.	</label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>de Martel</surname>
                     <given-names>C</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Plummer</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Vignat</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Franceschi</surname>
                     <given-names>S</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Worldwide burden of cancer attributable to HPV by site, country and HPV type</article-title>. 
                    <source>Int J Cancer</source>. 
                    <year>2017</year>
                    <month>Aug</month>;
                    <volume>141</volume>(
                    <issue>4</issue>):
                    <fpage>664</fpage>–
                    <lpage>70</lpage>. 
                    <pub-id pub-id-type="doi">10.1002/ijc.30716</pub-id>
                    <pub-id pub-id-type="pmid">28369882</pub-id>
                    <issn>0020-7136</issn>
                </mixed-citation>
         </ref>
         <ref id="b31">
            <label>31. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Haeggblom</surname>
                     <given-names>L</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Ramqvist</surname>
                     <given-names>T</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Tommasino</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Dalianis</surname>
                     <given-names>T</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Näsman</surname>
                     <given-names>A</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Time to change perspectives on HPV in oropharyngeal cancer. A systematic review of HPV prevalence per oropharyngeal sub-site the last 3 years</article-title>. 
                    <source>Papillomavirus Res</source>. 
                    <year>2017</year>
                    <month>Dec</month>;
                    <volume>4</volume>:
                    <fpage>1</fpage>–
                    <lpage>11</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.pvr.2017.05.002</pub-id>
                    <pub-id pub-id-type="pmid">29179862</pub-id>
                    <issn>2405-8521</issn>                     
                </mixed-citation>
         </ref>
         <ref id="b32">
            <label>32. </label>
            <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author">
                    <collab>Public Health England. National Cancer Registration and Analysis Service, NCRAS</collab>. 
                    </person-group>.
                    <source>The importance of skin cancer registration – NCIN data briefing</source>. 
                    <comment>Available from:<uri>http://www.ncin.org.uk/publications/data_briefings/skin_cancer_registration</uri>
               </comment>.
            </mixed-citation>
         </ref>
         <ref id="b33">
            <label>33. </label>
            <mixed-citation publication-type="book">
                <source>Rak v Sloveniji 2017</source>. 
                <publisher-loc>Ljubljana</publisher-loc>:
                <publisher-name>Onkološki inštitut Ljubljana, Epidemiologija in register raka, Register Raka Republike Slovenije</publisher-name>;
                <year>2017</year>. pp.
                <fpage>9</fpage>-
                <lpage>11</lpage>.
            </mixed-citation>
         </ref>
         <ref id="b34">
            <label>34. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Anselmo Lima</surname>
                     <given-names>C</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Sampaio Lima</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Maria Da Silva</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Prado Nunes</surname>
                     <given-names>MA</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Macedo Lima</surname>
                     <given-names>MM</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Oliveira Santos</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Do cancer registries play a role in determining the incidence of non-melanoma skin cancers?</article-title>
                    <source>Eur J Dermatol</source>. 
                    <year>2018</year>
                    <month>Apr</month>;
                    <volume>28</volume>(
                    <issue>2</issue>):
                    <fpage>169</fpage>–
                    <lpage>76</lpage>. 
                    <pub-id pub-id-type="doi">10.1684/ejd.2018.3248</pub-id>
                    <pub-id pub-id-type="pmid">29619990</pub-id>
                    <issn>1167-1122</issn>
                </mixed-citation>
         </ref>
         <ref id="b35">
            <label>35. </label>
            <mixed-citation publication-type="web-page">
                    <article-title>Slovenija : Slovenija in rak; Osnovni epidemiološki podatki o raku. Glava in vrat (C00–C14, C30–C32)</article-title>.
                    <year>2018</year>.
                    <date-in-citation content-type="access-date">[cited 2018 Mar 16]</date-in-citation>.
                    <comment>Available from:<uri>http://www.slora.si/c/document_library/get_file?uuid=e320aca2-d106-4478-8f0e-125255c5792e&amp;groupId=11561</uri>
               </comment>.
            </mixed-citation>
         </ref>
         <ref id="b36">
            <label>36. </label>
            <mixed-citation publication-type="web-page">
                    <person-group person-group-type="author">
                        <collab>Nacionalni inštitut za varno zdravje</collab>.
                    </person-group>. 
                    <article-title>Slovenija. Varno s soncem v vrtcih</article-title>.
                    <year>2019</year>.
                    <date-in-citation content-type="access-date">[cited 2019 Mar 22]</date-in-citation>]. 
                <comment>Available from:<uri>http://www.nijz.si/sl/program-varno-s-soncem-v-vrtcih</uri>
               </comment>.
                </mixed-citation>
         </ref>
         <ref id="b37">
            <label>37. </label>
            <mixed-citation publication-type="web-page">
                    <person-group person-group-type="author">
                            <collab>Nacionalni inštitut za varno zdravje</collab>.
                    </person-group>. 
                    <article-title>Slovenija. Varno s soncem v osnovnih šolah</article-title>. 
                    <year>2019</year> 
                    <date-in-citation content-type="access-date">cited 2019 Mar 22</date-in-citation>]. 
                <comment>Available from:<uri>http://www.nijz.si/sl/program-varno-s-soncem-v-osnovnih-solah</uri>
               </comment>.
                </mixed-citation>
         </ref>
         <ref id="b38">
            <label>38. </label>
            <mixed-citation publication-type="journal">
                    <article-title>Zakon o omejevanju uporabe tobačnih izdelkov</article-title>.
                    <source>Ur l RS</source>. 
                    <year>1996</year>.(                    
                    <issue>57</issue>),
                    <year>2002</year>.(                    
                    <issue>119</issue>),
                    <year>2005</year>.(                    
                    <issue>101</issue>),
                    <year>2007</year>.(                    
                    <issue>60</issue>).
                  </mixed-citation>
         </ref>
         <ref id="b39">
            <label>39. </label>
            <mixed-citation publication-type="journal">
                    <article-title>Zakon o omejevanju porabe alkohola – ZOPA</article-title>.  
                    <source>Ur l RS</source>. 
                    <year>2003</year>.(                    
                    <issue>15</issue>).
                </mixed-citation>
         </ref>
         <ref id="b40">
            <label>40. </label>
            <mixed-citation publication-type="book">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Toš</surname>
                     <given-names>N</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Klinar</surname>
                     <given-names>P</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Markič</surname>
                     <given-names>B</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Roter</surname>
                     <given-names>Z</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Vreg</surname>
                     <given-names>F</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Trampuž</surname>
                     <given-names>C</given-names>
                  </name>
                    </person-group>. 
                    <source>Slovenian Public Opinion survey 1978</source>. 
                    <publisher-loc>Ljubljana</publisher-loc>: 
                    <publisher-name>Faculty of Social Sciences University of Ljubljana and Public Opinion and Mass Communication Research Centre</publisher-name>; 
                    <year>1978</year>.
                </mixed-citation>
         </ref>
         <ref id="b41">
            <label>41.	</label>
            <mixed-citation publication-type="book-chapter">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Koprivnikar</surname>
                     <given-names>H</given-names>
                  </name>                         
                    </person-group>. 
                    <article-title>Tobak</article-title>. 
                    <comment>In</comment>:
                    <person-group person-group-type="editor">
                        <name name-style="western">
                     <surname>Zakotnik</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Tomšič</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Kofol Bric</surname>
                     <given-names>T</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Korošec</surname>
                     <given-names>I</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Zaletel-Kragelj</surname>
                     <given-names>L</given-names>
                  </name>, 
                        <role>eds</role>
                    </person-group>. 
                    <source>Zdravje in vedenjski slog prebivalcev Slovenije – trendi v raziskavah CINDI 2001–2004–2008</source>. 
                    <publisher-loc>Ljubljana</publisher-loc>:  
                    <publisher-name>Inštitut za varovanje zdravja Republike Slovenije</publisher-name>; 
                    <year>2012</year>. pp.
                    <fpage>71</fpage>-  
                    <lpage>88</lpage>.                     
                </mixed-citation>
         </ref>
         <ref id="b42">
            <label>42. </label>
            <mixed-citation publication-type="book-chapter">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Lovrečič</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Lovrečič</surname>
                     <given-names>B</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Tomšič</surname>
                     <given-names>S</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Alkohol</article-title>. 
                    <comment>In</comment>:
                    <person-group person-group-type="editor">
                        <name name-style="western">
                     <surname>Zakotnik</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Tomšič</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Kofol Bric</surname>
                     <given-names>T</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Korošec</surname>
                     <given-names>I</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Zaletel-Kragelj</surname>
                     <given-names>L</given-names>
                  </name>, 
                        <role>eds</role>
                    </person-group>. 
                    <source>Zdravje in vedenjski slog prebivalcev Slovenije – trendi v raziskavah CINDI 2001–2004–2008</source>. 
                    <publisher-loc>Ljubljana</publisher-loc>:  
                    <publisher-name>Inštitut za varovanje zdravja Republike Slovenije</publisher-name>; 
                    <year>2012</year>. pp.
                    <fpage>89</fpage>-  
                    <lpage>107</lpage>.  
                </mixed-citation>
         </ref>
         <ref id="b43">
            <label>43. </label>
            <mixed-citation publication-type="book-chapter">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Lovrečič</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Lovrečič</surname>
                     <given-names>B</given-names>
                  </name>
                    </person-group>. 
                    <chapter-title>Pitje alkohola</chapter-title>.
                    <comment>In</comment>:
                    <person-group person-group-type="editor">
                        <name name-style="western">
                     <surname>Vinko</surname>
                     <given-names>M</given-names>
                  </name>,                         
                        <name name-style="western">
                     <surname>Kofol Bric</surname>
                     <given-names>T</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Korošec</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Tomšič</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Vrdelja</surname>
                     <given-names>M</given-names>
                  </name> 
                        <role>eds</role>.
                    </person-group>. 
                    <source>Kako skrbimo za zdravje? Z zdravjem povezan vedenjski slog prebivalcev Slovenije 2016</source>. 
                    <publisher-loc>Ljubljana</publisher-loc>:  
                    <publisher-name>Inštitut za varovanje zdravja Republike Slovenije</publisher-name>; 
                    <year>2018</year>. pp.
                    <fpage>17</fpage>-  
                    <lpage>20</lpage>.                       
                </mixed-citation>
         </ref>
         <ref id="b44">
            <label>44. </label>
            <mixed-citation publication-type="book">
                <source>WHO | Global information system on alcohol and health</source>. 
                <comment>Available from:<uri>https://www.who.int/gho/alcohol/en/</uri>
               </comment>.   
                </mixed-citation>
         </ref>
         <ref id="b45">
            <label>45. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bravi</surname>
                     <given-names>F</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Edefonti</surname>
                     <given-names>V</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Randi</surname>
                     <given-names>G</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Ferraroni</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>La Vecchia</surname>
                     <given-names>C</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Decarli</surname>
                     <given-names>A</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Dietary patterns and upper aerodigestive tract cancers: an overview and review</article-title>. 
                    <source>Ann Oncol</source>. 
                    <year>2012</year>
                    <month>Dec</month>;
                    <volume>23</volume>(
                    <issue>12</issue>):
                    <fpage>3024</fpage>–
                    <lpage>39</lpage>. 
                    <pub-id pub-id-type="doi">10.1093/annonc/mds197</pub-id>
                    <pub-id pub-id-type="pmid">22967993</pub-id>
                    <issn>0923-7534</issn>
                </mixed-citation>
         </ref>
         <ref id="b46">
            <label>46. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Olaleye</surname>
                     <given-names>O</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Ekrikpo</surname>
                     <given-names>U</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Lyne</surname>
                     <given-names>O</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Wiseberg</surname>
                     <given-names>J</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Incidence and survival trends of lip, intra-oral cavity and tongue base cancers in south-east England</article-title>. 
                    <source>Ann R Coll Surg Engl</source>. 
                    <year>2015</year>
                    <month>Apr</month>;
                    <volume>97</volume>(
                    <issue>3</issue>):
                    <fpage>229</fpage>–
                    <lpage>34</lpage>. 
                    <pub-id pub-id-type="doi">10.1308/003588414X14055925061676</pub-id>
                    <pub-id pub-id-type="pmid">26263810</pub-id>
                    <issn>0035-8843</issn>
                </mixed-citation>
         </ref>
         <ref id="b47">
            <label>47.	</label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>van Dijk</surname>
                     <given-names>BA</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Brands</surname>
                     <given-names>MT</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Geurts</surname>
                     <given-names>SM</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Merkx</surname>
                     <given-names>MA</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Roodenburg</surname>
                     <given-names>JL</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Trends in oral cavity cancer incidence, mortality, survival and treatment in the Netherlands</article-title>. 
                    <source>Int J Cancer</source>. 
                    <year>2016</year>
                    <month>Aug</month>;
                    <volume>139</volume>(
                    <issue>3</issue>):
                    <fpage>574</fpage>–
                    <lpage>83</lpage>. 
                    <pub-id pub-id-type="doi">10.1002/ijc.30107</pub-id>
                    <pub-id pub-id-type="pmid">27038013</pub-id>
                    <issn>0020-7136</issn>
                </mixed-citation>
         </ref>
         <ref id="b48">
            <label>48. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Johansen</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Grau Eriksen</surname>
                     <given-names>J</given-names>
                  </name>; 
                        <collab>Academy of Geriatric Cancer Research (AgeCare)</collab>
                    </person-group>. 
                    <article-title>Trends in cancer of the head and neck in the elderly in Denmark, 1980-2012</article-title>. 
                    <source>Acta Oncol</source>. 
                    <year>2016</year>;
                    <volume>55</volume>(
                    <issue>sup1</issue>
                    <supplement>Suppl 1</supplement>):
                    <fpage>13</fpage>–
                    <lpage>8</lpage>. 
                    <pub-id pub-id-type="doi">10.3109/0284186X.2015.1114672</pub-id>
                    <pub-id pub-id-type="pmid">26760291</pub-id>
                    <issn>0284-186X</issn>
                </mixed-citation>
         </ref>
         <ref id="b49">
            <label>49. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Kingsley</surname>
                     <given-names>K</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>O’Malley</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Ditmyer</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Chino</surname>
                     <given-names>M</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Analysis of oral cancer epidemiology in the US reveals state-specific trends: Implications for oral cancer prevention</article-title>. 
                    <source>BMC Public Health</source>. 
                    <year>2018</year>;
                    <volume>8</volume>:          
                    <fpage>87</fpage>.
                    <pub-id pub-id-type="doi">10.1186/1471-2458-8-87</pub-id>
                    <pub-id pub-id-type="pmid">18331638</pub-id>
                    <issn>1471-2458</issn>                 
                </mixed-citation>
         </ref>
         <ref id="b50">
            <label>50. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Elwood</surname>
                     <given-names>JM</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Youlden</surname>
                     <given-names>DR</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Chelimo</surname>
                     <given-names>C</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Ioannides</surname>
                     <given-names>SJ</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Baade</surname>
                     <given-names>PD</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Comparison of oropharyngeal and oral cavity squamous cell cancer incidence and trends in New Zealand and Queensland, Australia</article-title>. 
                    <source>Cancer Epidemiol</source>. 
                    <year>2014</year>
                    <month>Feb</month>;
                    <volume>38</volume>(
                    <issue>1</issue>):
                    <fpage>16</fpage>–
                    <lpage>21</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.canep.2013.12.004</pub-id>
                    <pub-id pub-id-type="pmid">24445141</pub-id>
                    <issn>1877-7821</issn>
                </mixed-citation>
         </ref>
         <ref id="b51">
            <label>51. </label>
            <mixed-citation publication-type="web-page">
                    <person-group person-group-type="author">
                        <collab>Onkološki inštitut=Institut of Oncology Ljubljana</collab>
                    </person-group>. 
                    <article-title>Register raka Republike Slovenije in drugi registri</article-title>.                      
                    <year>2018</year>.
                    <date-in-citation content-type="access-date">[cited 2018 Jun 3]</date-in-citation>. 
                    <comment>Available from:<uri>https://www.onko-i.si/rrs/</uri>
               </comment>.
                </mixed-citation>
         </ref>
         <ref id="b52">
            <label>52. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Tapia</surname>
                     <given-names>JL</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Goldberg</surname>
                     <given-names>LJ</given-names>
                  </name>
                    </person-group>. 
                    <article-title>The challenges of defining oral cancer: analysis of an ontological approach</article-title>. 
                    <source>Head Neck Pathol</source>. 
                    <year>2011</year>
                    <month>Dec</month>;
                    <volume>5</volume>(
                    <issue>4</issue>):
                    <fpage>376</fpage>–
                    <lpage>84</lpage>. 
                    <pub-id pub-id-type="doi">10.1007/s12105-011-0300-0</pub-id>
                    <pub-id pub-id-type="pmid">21915705</pub-id>
                    <issn>1936-055X</issn>
                </mixed-citation>
         </ref>
         <ref id="b53">
            <label>53. </label>
            <mixed-citation publication-type="web-page">
                    <source>Head and neck cancers. What are cancers of the head and neck?</source>
                    <year>2017</year>.
                    <comment>Available from:<uri>https://www.cancer.gov/types/head-and-neck/head-neck-fact-sheet</uri>
               </comment>.
                </mixed-citation>
         </ref>
         <ref id="b54">
            <label>54. </label>
            <mixed-citation publication-type="book-chapter">
                    <person-group person-group-type="editor">
                        <name name-style="western">
                     <surname>Amin</surname>
                     <given-names>MB</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Edge</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Greene</surname>
                     <given-names>F</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Byrd</surname>
                     <given-names>DR</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Brookland</surname>
                     <given-names>RK</given-names>
                  </name>,
                        <name name-style="western">
                     <surname>Washington</surname>
                     <given-names>MK</given-names>
                  </name>, 
                        <etal>et al.</etal>,
                        <role>eds</role>
                    </person-group>. 
                    <source>AJCC Cancer Staging Manual</source>.
                    <edition>8th ed</edition>.
                    <publisher-loc>Chicago</publisher-loc>: 
                    <publisher-name>Springer</publisher-name>; 
                    <year>2017</year>.                 
                </mixed-citation>
         </ref>
         <ref id="b55">
            <label>55. </label>
            <mixed-citation publication-type="book">
               <person-group person-group-type="editor">
                  <name name-style="western">
                     <surname>Lui</surname>
                     <given-names>JC</given-names>
                  </name>, 
                  <name name-style="western">
                     <surname>Pagedar</surname>
                     <given-names>NA</given-names>
                  </name>, 
                  <name name-style="western">
                     <surname>Goldenberg</surname>
                     <given-names>D</given-names>
                  </name>, 
                  <name name-style="western">
                     <surname>Gross</surname>
                     <given-names>ND</given-names>
                  </name>, 
                  <role>eds</role>
               </person-group>
              <source>Oral cavity cancer</source>. 
              <publisher-loc>Los Angeles, CA</publisher-loc>: 
               <publisher-name>American Head and Neck Society</publisher-name>; 
              <year>2017</year>.
             </mixed-citation>
         </ref>
         <ref id="b56">
            <label>56. </label>
            <mixed-citation publication-type="book">
                    <source>Oral cavity and oropharyngeal cancer. What are oral cavity and oropharyngeal cancers?</source>
                    <comment>Available from:<uri>https://www.cancer.org/content/dam/CRC/PDF/Public/8763.00.pdf</uri>
               </comment>.
                </mixed-citation>
         </ref>
         <ref id="b57">
            <label>57. </label>
            <mixed-citation publication-type="web-page">
                    <source>Mouth and oropharyngeal cancer. About mouth and oropharyngeal cancer</source>. 
                    <comment>Available from:<uri>https://www.cancerresearchuk.org/about-cancer/mouth-cancer/about</uri>
               </comment>.
                </mixed-citation>
         </ref>
         <ref id="b58">
            <label>58. </label>
            <mixed-citation publication-type="book-chapter">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Gašperšič</surname>
                     <given-names>D</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Košir</surname>
                     <given-names>N</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Jevnikar</surname>
                     <given-names>N</given-names>
                  </name>
                    </person-group>. 
                    <chapter-title>Razvoj obraza in ustne votline</chapter-title>.
                    <comment>In</comment>: 
                    <person-group person-group-type="editor">
                        <name name-style="western">
                     <surname>Gašperšič</surname>
                     <given-names>C</given-names>
                  </name>
                        <role>ed</role>
                    </person-group>. 
                    <source>Razvoj obraza, ustne votline in zobnega organa</source>. 
                        <edition>2nd ed</edition>. 
                        <publisher-loc>Ljubljana</publisher-loc>: 
                        <publisher-name>Medicinska fakulteta</publisher-name>;                         
                        <year>2002</year>. pp. 
                        <fpage>7</fpage>- 
                        <fpage>25</fpage>.                     
                </mixed-citation>
         </ref>
         <ref id="b59">
            <label>59. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Trotta</surname>
                     <given-names>BM</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Pease</surname>
                     <given-names>CS</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Rasamny</surname>
                     <given-names>JJ</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Raghavan</surname>
                     <given-names>P</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Mukherjee</surname>
                     <given-names>S</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Oral cavity and oropharyngeal squamous cell cancer: key imaging findings for staging and treatment planning</article-title>. 
                    <source>Radiographics</source>. 
                    <year>2011</year>
                    <month>Mar-Apr</month>;
                    <volume>31</volume>(
                    <issue>2</issue>):
                    <fpage>339</fpage>–
                    <lpage>54</lpage>. 
                    <pub-id pub-id-type="doi">10.1148/rg.312105107</pub-id>
                    <pub-id pub-id-type="pmid">21415183</pub-id>
                    <issn>0271-5333</issn>
                </mixed-citation>
         </ref>
         <ref id="b60">
            <label>60. </label>
            <mixed-citation publication-type="web-page">
                    <source>What Are the Risk Factors and Potential Causes for Salivary Gland Cancer?</source>
                    <year>2018</year>.
                    <date-in-citation content-type="access-date">[cited 2018 Jun 3]</date-in-citation>. 
                <comment>Available from:<uri>https://www.cancer.org/cancer/salivary-gland-cancer/causes-risks-prevention/risk-factors.html</uri>
               </comment>.
                </mixed-citation>
         </ref>
         <ref id="b61">
            <label>61.	</label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Tsao</surname>
                     <given-names>SW</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Yip</surname>
                     <given-names>YL</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Tsang</surname>
                     <given-names>CM</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Pang</surname>
                     <given-names>PS</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Lau</surname>
                     <given-names>VM</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Zhang</surname>
                     <given-names>G</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Etiological factors of nasopharyngeal carcinoma</article-title>. 
                    <source>Oral Oncol</source>. 
                    <year>2014</year>
                    <month>May</month>;
                    <volume>50</volume>(
                    <issue>5</issue>):
                    <fpage>330</fpage>–
                    <lpage>8</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.oraloncology.2014.02.006</pub-id>
                    <pub-id pub-id-type="pmid">24630258</pub-id>
                    <issn>1368-8375</issn>
                </mixed-citation>
         </ref>
         <ref id="b62">
            <label>62. </label>
            <mixed-citation publication-type="book-chapter">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Zeng</surname>
                     <given-names>MS</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Zeng</surname>
                     <given-names>YX</given-names>
                  </name>
                    </person-group>. 
                    <chapter-title>Pathogenesis and etiology of nasopharyngeal carcinoma</chapter-title>. 
                    <comment>In</comment>: 
                    <person-group person-group-type="editor">
                        <name name-style="western">
                     <surname>Lu</surname>
                     <given-names>JJ</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Cooper</surname>
                     <given-names>JS</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Lee</surname>
                     <given-names>AW</given-names>
                  </name>, 
                        <role>eds</role>
                    </person-group>. 
                    <source>Nasopharyngeal Cancer: Multidisciplinary Management</source>.
                    <publisher-loc>Berlin</publisher-loc>:
                    <publisher-name>Springer Science &amp; Business Media</publisher-name>; 
                    <year>2010</year>. pp. 
                    <fpage>9</fpage>–
                    <lpage>25</lpage>. 
                    <pub-id pub-id-type="doi">10.1007/978-3-540-92810-2_2</pub-id>                    
                </mixed-citation>
         </ref>
         <ref id="b63">
            <label>63. </label>
            <mixed-citation publication-type="web-page">
                    <source>Zora. Državni program zgodnjega odkrivanja predrakavih sprememb materničnega vratu</source>.  
                    <year>2018</year>.
                    <date-in-citation content-type="access-date">[cited 2019 Mar 7]</date-in-citation>. 
                    <comment>Available from:<uri>https://zora.onko-i.si/za-zenske/preprecevanje-rmv/</uri>
               </comment>.
                </mixed-citation>
         </ref>
         <ref id="b64">
            <label>64. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Muñoz</surname>
                     <given-names>N</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Kjaer</surname>
                     <given-names>SK</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Sigurdsson</surname>
                     <given-names>K</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Iversen</surname>
                     <given-names>OE</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Hernandez-Avila</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Wheeler</surname>
                     <given-names>CM</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women</article-title>. 
                    <source>J Natl Cancer Inst</source>. 
                    <year>2010</year>
                    <month>Mar</month>;
                    <volume>102</volume>(
                    <issue>5</issue>):
                    <fpage>325</fpage>–
                    <lpage>39</lpage>. 
                    <pub-id pub-id-type="doi">10.1093/jnci/djp534</pub-id>
                    <pub-id pub-id-type="pmid">20139221</pub-id>
                    <issn>0027-8874</issn>
                </mixed-citation>
         </ref>
         <ref id="b65">
            <label>65. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Giuliano</surname>
                     <given-names>AR</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Palefsky</surname>
                     <given-names>JM</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Goldstone</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Moreira</surname>
                     <given-names>ED</given-names>
                     <suffix>Jr</suffix>
                  </name>, 
                        <name name-style="western">
                     <surname>Penny</surname>
                     <given-names>ME</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Aranda</surname>
                     <given-names>C</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males</article-title>. 
                    <source>N Engl J Med</source>. 
                    <year>2011</year>
                    <month>Feb</month>;
                    <volume>364</volume>(
                    <issue>5</issue>):
                    <fpage>401</fpage>–
                    <lpage>11</lpage>. 
                    <pub-id pub-id-type="doi">10.1056/NEJMoa0909537</pub-id>
                    <pub-id pub-id-type="pmid">21288094</pub-id>
                    <issn>0028-4793</issn>
                </mixed-citation>
         </ref>
         <ref id="b66">
            <label>66.	</label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Guo</surname>
                     <given-names>T</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Eisele</surname>
                     <given-names>DW</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Fakhry</surname>
                     <given-names>C</given-names>
                  </name>
                    </person-group>. 
                    <article-title>The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer</article-title>. 
                    <source>Cancer</source>. 
                    <year>2016</year>
                    <month>Aug</month>;
                    <volume>122</volume>(
                    <issue>15</issue>):
                    <fpage>2313</fpage>–
                    <lpage>23</lpage>. 
                    <pub-id pub-id-type="doi">10.1002/cncr.29992</pub-id>
                    <pub-id pub-id-type="pmid">27152637</pub-id>
                    <issn>0008-543X</issn>
                </mixed-citation>
         </ref>
         <ref id="b67">
            <label>67. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Arbyn</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>de Sanjosé</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Saraiya</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Sideri</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Palefsky</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Lacey</surname>
                     <given-names>C</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease</article-title>. 
                    <source>Int J Cancer</source>. 
                    <year>2012</year>
                    <month>Nov</month>;
                    <volume>131</volume>(
                    <issue>9</issue>):
                    <fpage>1969</fpage>–
                    <lpage>82</lpage>. 
                    <pub-id pub-id-type="doi">10.1002/ijc.27650</pub-id>
                    <pub-id pub-id-type="pmid">22623137</pub-id>
                    <issn>0020-7136</issn>
                </mixed-citation>
         </ref>
         <ref id="b68">
            <label>68.	</label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Cobos</surname>
                     <given-names>C</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Figueroa</surname>
                     <given-names>JA</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Mirandola</surname>
                     <given-names>L</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Colombo</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Summers</surname>
                     <given-names>G</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Figueroa</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>The role of human papilloma virus (HPV) infection in non-anogenital cancer and the promise of immunotherapy: a review</article-title>. 
                    <source>Int Rev Immunol</source>. 
                    <year>2014</year>
                    <month>Oct</month>;
                    <volume>33</volume>(
                    <issue>5</issue>):
                    <fpage>383</fpage>–
                    <lpage>401</lpage>. 
                    <pub-id pub-id-type="doi">10.3109/08830185.2014.911857</pub-id>
                    <pub-id pub-id-type="pmid">24811210</pub-id>
                    <issn>0883-0185</issn>
                </mixed-citation>
         </ref>
         <ref id="b69">
            <label>69. </label>
            <mixed-citation publication-type="conference">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Terlević Dabić</surname>
                     <given-names>D</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Vloga zobozdravnika – preventiva in zgodnje odkrivanje raka ustne votline</article-title>. 
                    <comment>In</comment>: 
                    <person-group person-group-type="editor">
                        <name name-style="western">
                     <surname>Kansky</surname>
                     <given-names>A</given-names>
                  </name>,
                        <name name-style="western">
                     <surname>Terlević Dabić</surname>
                     <given-names>D</given-names>
                  </name>,   
                        <role>eds</role>
                    </person-group>. 
                    <source>Zobozdravnik vidi bolje. Zato lahko reši življenje : Zbornik predavanj</source>;
                    <conf-date>2017 Mar 18</conf-date>;
                    <conf-loc>Ljubljana, Slovenia</conf-loc>. 
                    <publisher-loc>Ljubljana</publisher-loc>:
                    <publisher-name>Zdravniška zbornica Slovenije</publisher-name>;                         
                    <year>2017</year>. pp. 
                    <fpage>6</fpage>- 
                    <fpage>10</fpage>.   
                </mixed-citation>
         </ref>
         <ref id="b70">
            <label>70. </label>
            <mixed-citation publication-type="book-chapter">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Kocjančič</surname>
                     <given-names>A</given-names>
                  </name>
                    </person-group>. 
                    <chapter-title>Telesna preiskava</chapter-title>.
                    <comment>In</comment>: 
                    <person-group person-group-type="editor">
                        <name name-style="western">
                     <surname>Kocijančič</surname>
                     <given-names>A</given-names>
                  </name>                     
                        <role>ed</role>
                    </person-group>. 
                    <source>Klinična preiskava</source>. 
                    <publisher-loc>Ljubljana</publisher-loc>: 
                    <publisher-name>Littera picta</publisher-name>;                         
                    <year>2017</year>. pp. 
                    <fpage>10</fpage>.
                </mixed-citation>
         </ref>
         <ref id="b71">
            <label>71. </label>
            <mixed-citation publication-type="web-page">
                    <source>Smernice za zdravljenje tumorjev glave in vratu</source>.
                    <year>2018</year>.
                    <date-in-citation content-type="access-date">[cited 2018 Jun 3]</date-in-citation>]. 
                    <comment>Available from:<uri>https://www.onko-i.si/fileadmin/_migrated/content_uploads/Smernice_za_obravnavo_rakov_glave_in_vratu_01.pdf</uri>
               </comment>. 
            </mixed-citation>
         </ref>
         <ref id="b72">
            <label>72. </label>
            <mixed-citation publication-type="web-page">
                    <source>WHO | Evropski kodeks proti raku</source>.                     
                    <year>2019</year>  
                    <date-in-citation content-type="access-date">cited 2019 Mar 8</date-in-citation>]. 
                    <comment>Available from:<uri>https://cancer-code-europe.iarc.fr/index.php/sl/</uri>
               </comment>.
                </mixed-citation>
         </ref>
      </ref-list>
   </back>
</article>
